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SUMMARY 
Treatment of psychotic disorders has mainly focused on reducing positive psychotic 
symptoms, while comorbid disorders such as anxiety and depression have received less 
attention. There seems to be two main reasons for this. Firstly, there has been a general lack 
of awareness of other symptom dimensions co-occurring in psychosis due to the hierarchical 
approach to diagnostic evaluations. Symptoms of emotional dysfunction, defined as mood 
symptoms and/or anxiety disorders following the Diagnostic and Statistical Manual of 
mental disorders (DSM-IV), have not been acknowledged because they are regarded less 
important in severe psychotic disorders both with regard to diagnosis and treatment. 
Secondly, studies show  that even though clinicians acknowledge the co-occurrence of other 
symptom dimensions, there is no consensus as to whether it should be treated as a separate 
condition or not (Addington et al., 2002).  
The current thesis focused on depression and social anxiety and seeks to conceptualize these 
co-occurring symptom dimensions in the context of psychotic disorders.  Depression and 
social anxiety interact, as people afflicted by these disorders have a common tendency to 
make negative evaluations of themselves in relation to others and the world. Embedded in 
this context lies a feeling of inferiority and low self-esteem.  Consequently, a focus on self-
esteem was natural.  
In the first paper (paper I) we investigated the prevalence and time course of lifetime major 
depressive episodes in first episode psychosis (FEP) and examined whether there were 
differences between those with and without previous episodes. We also examined possible 
contributing factors to development of depressive symptomatology. Almost 50% of the 
sample had experienced one or more lifetime episodes of major depression, with no 
indications of demographic or clinical differences. Poor premorbid childhood adjustment, 
substance abuse and excitative symptoms were associated with higher levels of current 
depressive symptomatology. Furthermore, findings indicated possible gender differences 
regarding alcohol and excitative symptoms as possible explanatory factors related to 
depressive symptoms. Alcohol use was associated with current severity of depression in men 
while excitative symptoms were associated in women.  
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In the second paper (paper II) we examined whether premorbid adjustment was associated 
with the afflicted individuals’ self-esteem and whether lowered self-esteem may contribute 
to the development of delusions and hallucinations in FEP. We found indications that 
premorbid adjustment was an important factor in the development of self-esteem, and that 
reduced self-esteem was significantly associated with raised level of positive psychotic 
symptoms.  
The third and fourth papers (paper III and IV) were concerned with symptoms of social 
anxiety disorder. Paper III was a psychometric paper aimed at validating the Liebowitz Social 
Anxiety Scale – self-rated version. This is a widely used scale, but the self-rated version has 
never been validated when applied to psychotic disorders. We reproduced factor analytically 
derived subscales similar to those found elsewhere in the literature in non-psychotic 
samples. Furthermore, the scales showed satisfactory psychometric properties. Additionally, 
we found support for the assumption that the scale measures social anxiety as an 
independent domain in psychotic disorders.  
In paper IV we found that severe social anxiety was related to poor premorbid- and current 
functioning in addition to level of depression, but not to level of current psychotic 
symptoms. Insight into illness was more related to level of social anxiety and depression 
than to psychotic symptoms. Furthermore, higher level of social anxiety and depression 
were associated with poorer quality of life.   
The findings of the present thesis support the relevance of an active approach towards 
recognition and treatment of emotional dysfunction as it is prevalent and constitutes a 
major additional burden for patients with a first episode of psychosis.  
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1. INTRODUCTION 
1.1. Perspectives and definitions 
1.1.1. Psychosis 
Several definitions of psychosis are in use. The most narrow one restricts psychosis to 
‘delusions or prominent hallucinations, with the hallucinations occurring in the absence of 
insight into their pathological nature’(American Psychiatric Association, 1994). A broader 
definition includes hallucinations and delusions even when the individual accepts the 
experience as a result of reality distortion, while the broadest definition comprises 
disorganized speech, grossly disorganized or catatonic behaviour. Furthermore, psychosis 
occurs across a range of diagnostic categories of psychotic disorders such as; non affective 
psychotic disorder, affective psychoses, substance-induced psychotic disorder and psychotic 
disorder due to a general medical condition. 
Currently there is an ongoing debate concerning the relationship between psychosis and 
diagnostic categories as they do not seem to represent discrete nosological entities (Linscott 
et al., 2010). A growing body of evidence suggest overlap between the psychotic diagnostic 
categories in genetic liability, and even between schizophrenia and bipolar disorder 
(Lichtenstein et al., 2009). There might instead be broader susceptibility for psychotic 
disorders that is expressed across the different diagnostic categories, also reflected in similar 
clinical characteristics (Simonsen et al., 2009). Furthermore, there is research suggesting that 
symptoms previously considered to be characteristic of psychotic disorders are prevalent in 
the community at large (van Os et al., 2000). These subclinical psychotic experiences are in 
most cases transitory and are typically expressed in adolescence and young adulthood 
(Hanssen et al., 2005). A recent systematic review advocates for the psychosis continuum 
model by finding evidence for a ‘psychosis proneness-persistence-impairment model’ of 
psychotic disorder (van Os et al., 2009). In this model, the usually transitory psychotic 
experiences can be modified to more persistent psychotic experiences with clinical need for 
care due to exposure to environmental and psychological risk factors such as psychological 
trauma, cannabis or urbanicity. However, the underlying pathological mechanisms for this 
rare transition are still unknown.  
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1.1.2. First episode psychosis 
Considering the continuum hypothesis, research into the early phases of psychotic disorders 
is particularly relevant as the different contributing factors that are in play during transition 
from normality to pathology will be present. The danger of misinterpreting research findings 
due to chronicity, recall bias or the effects of long-term medication is reduced during early 
stages of the disorder.  There exists a substantial literature stating the importance of early 
detection and intervention.  Embedded in this logic is an understanding of psychotic disorder 
as a dynamic, biopsychosocial, reversible process, which can be prevented, delayed, 
modified and reversed (Read, 2004). This thesis will focus on patients with a first episode of 
psychosis; excluding substance induced psychotic disorder and psychotic disorder due to a 
general medical condition. 
1.1.3. Diagnostic criteria 
There are several subgroups comprised by the term psychotic disorder in the various 
classification systems such as the DSM and the ICD. The basis for the patient samples studied 
in this thesis is the broader schizophrenia spectrum disorders included in the DSM-IV: 
Schizophrenia, Schizoaffective disorder, Schizophreniform disorder, Delusional disorder, 
Brief psychotic disorder and Psychotic disorder Not Otherwise Specified (NOS). Furthermore, 
the diagnostic category Major depressive episode with mood incongruent symptoms is 
included. 
Schizophrenia is considered the most severe of the psychotic disorders. As defined in the 
DSM-IV diagnostic system, the symptoms have to be present for more than 6 months and 
include at least one month of active-phase symptoms. Active phase symptoms include two 
(or more) of the following: delusions, hallucinations, disorganized speech, grossly 
disorganized or catatonic behaviour or negative symptoms (Criterion A). In addition, a 
significant reduction in social functioning in comparison to former level of achievement must 
be present (Criterion B). Even though there are defined subtypes (Paranoid, Disorganized, 
Catatonic, Undifferentiated and Residual) the clinical picture varies greatly among patients 
within these subcategories, depending on which criteria the individual fulfil.  
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The prevalence rate of schizophrenia has usually been estimated to be between 0.5 % and 
1% (American Psychiatric Association, 1994). A recent review points to the fact that there 
are larger variations between sites than formerly recognized (McGrath et al., 2008). The 
authors found that the median lifetime prevalence for schizophrenia were 4.0 per 1,000 and 
for lifetime morbid risk 7.2 per 1,000. 
Age of onset differs, but in general, median age of onset is considered to be in adolescence 
and young adulthood for men and some years later for women. Most patients who develop 
schizophrenia have had a longer period prior to the first psychotic outbreak with unspecific, 
non-psychotic prodromal symptoms such as social withdrawal, loss of interest in school or 
work, depression and anxiety (Yung and McGorry, 1996;Hafner et al., 1999). On average, this 
period has been reported to last 1-2 years. Another aspect which is assumed to have an 
impact on the course and outcome of the disorder is the period from onset of manifest 
psychotic symptoms until onset of adequate treatment (the Duration of Untreated 
Psychosis-DUP) (Larsen et al., 1998;Melle et al., 2008). A long DUP is associated with poorer 
outcome (Melle et al., 2005;Marshall and Rathbone, 2006). 
There are several reasons why this disorder is rated as one of the most costly disorders in 
the Western world (approximately 1 % of the Gross National budget ) (Johannessen, 2002). 
Firstly, there are considerable costs due to expensive health care including medication and 
frequent use of health services. Furthermore, patients with schizophrenia may experience  
reduced cognitive capacity and less tolerance for stress (Green, 1996). These obstacles, 
combined with stigmatisation may also result in reduced ability to join the active work force. 
Treatment of these disorders is still challenging. The conventional approach is a focus on 
pharmacological treatment of positive psychotic symptoms in combination with psychosocial 
treatment and rehabilitation. Psychotherapy is offered to a limited extent, unfortunately still 
depending upon varying economic and professional resources available at the different 
treatment sites. 
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Schizophreniform Disorder is defined by the same symptom clusters that characterize 
schizophrenia, but the duration of manifest psychotic symptoms is shorter, from 1 to 6 
months. A decline in social functioning is not required. 
Schizoaffective Disorder: There must be an uninterrupted period of illness during wich there 
is either a Major Depressive Episode or a Manic Episode, or a Mixed Episode concurrent with 
symptoms that meet criterion A for Schizophrenia. 
Delusional Disorder is defined by minimum 1 month of non-bizarre delusions. Other active 
phase symptoms are not permitted. 
Brief Psychotic Disorder is limited to manifest symptoms of psychosis lasting for more than 
one day and less than one month. 
Psychotic Disorder (NOS) includes psychotic symptomatology, but where inadequate or 
contradictory information makes it impossible to draw firm conclusions about diagnosis, or 
disorders with psychotic symptoms that do not meet any of the criteria for a specific 
psychotic disorder.  
Major Depressive Episode with mood-incongruent psychotic symptoms (MDE) is 
characterized by a primary depressive episode with hallucinations or delusions that has no 
apparent relationship to the depressive themes. There are good reasons to include this 
group in the current thesis.  The psychotic symptoms resemble those seen in the psychotic 
disorders listed above. Some of these patients will eventually convert to a diagnosis within 
the schizophrenia spectrum after some time (Haahr et al., 2008). Furthermore, the 
continuum hypothesis combined with recent research indicating that the presence of a 
history of psychosis in bipolar disorder works as a common denominator predicting outcome 
in both schizophrenia patients and bipolar patients (Simonsen et al., 2009).  
1.1.4. Psychiatric comorbidity in psychotic disorders 
Psychiatric comorbidity is common in psychotic disorders. Nevertheless, the focus on co-
occurring syndromes has been neglected. This is partly due to the hierarchical foundation of 
the diagnostic system (Bermanzohn et al., 2000). As described by Surtees and Kendell;  
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“Psychiatric diagnosis are arranged in a hierarchy in which any given diagnosis excludes the 
symptoms of all higher members of the hierarchy and embraces the symptoms of the lower 
members” (Surtees and Kendell, 1979). There were made changes when moving from DSM-
III to DSM-IV to capture the heterogeneity of schizophrenia by: 1) permitting more than one 
diagnosis on Axis 1 and 2) changing the formulation of the exclusion rules (excludes lower 
diagnosis if they are ‘better accounted for by a higher order diagnosis) (Bermanzohn et al., 
2000). However there is still a lack of awareness of these potentially treatable comorbid 
conditions and a lack of common guidelines.  
A recent review concluded that substance abuse, depression and anxiety are the most 
common comorbid disorders in schizophrenia:  47 % of the patients will have a lifetime 
diagnosis of substance abuse, and 50 % experience depression. Furthermore, estimated 
lifetime prevalence for panic disorder was 15 %, for posttraumatic stress disorder 29 % and 
for obsessive/compulsive disorder 23 % (Buckley et al., 2009). Social anxiety disorder has 
received less attention, but epidemiologic studies have reported this to range between 14 % 
and 39% (Cosoff and Hafner, 1998;Pallanti et al., 2004;Bermanzohn et al., 2000;Cassano et 
al., 1999).  
1.2. Emotional dysfunction 
Recently, there has been an increasing interest in research concerning emotional 
dysfunction or the role of emotions in psychosis. Presumably because of a lack of clear 
definition, different terms have been applied in various studies. DSM-IV describes emotional 
dysfunction as a characteristic symptom of schizophrenia, but without providing a clear 
definition (American Psychiatric Association, 1994). The term emotional dysfunction has 
been used repeatedly to describe symptoms of mood and anxiety disorders, including PTSD 
and reduced self-esteem (Birchwood et al., 2005;Birchwood et al., 2006;Watson et al., 
2006;Smith et al., 2006). Other terms that have been used interchangeably with emotional 
dysfunction is emotional disturbances, emotional distress or emotional disorders (Green et 
al., 2006;Kuipers et al., 2006;Garety et al., 2001;Freeman et al., 2001;Garety et al., 
2005;Freeman and Garety, 2003). Despite the diverse nomenclature, the main focus has 
been on symptoms related to mood and anxiety disorders according to the diagnostic 
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criteria of DSM-IV. In the current thesis, the term emotional dysfunction will be used to 
describe symptoms of depression and anxiety, including reduced self-esteem. The basis for 
this choice is related to the theoretical framework in which the results of the present thesis 
will be contextualized.  
There seems to be mainly three reasons why emotional dysfunction in psychosis has 
received little attention. Historically, the division between neurosis and psychosis 
distinguishing ‘affective illness from madness proper’ by Jaspers, has made a huge impact 
upon how co-occurring symptomatology such as mood or anxiety disorders has been viewed 
in this context (Freeman and Garety, 2003;Jaspers, 1963). Even though neurosis as a concept 
dates back to the 18th century and then comprised both neurological and psychological 
states (Beer, 1996), it was the interpretation made by Freud during the 19th century that 
formally linked it to anxiety disorders, even though Freud himself later on declared that 
neuroses and psychoses were intimately related (Freud, 1924). It became accepted that in 
contrast to the psychosis, the neurosis let part of the premorbid person intact, including 
insight, while psychosis was viewed as  a mental state qualitatively different and 
psychologically irreducible (Roth, 1963). The heritage from this conceptualisation seems in 
part responsible for the lack of research on emotional difficulties in psychosis. It has to be 
noted that with DSM-III, the concept of neurosis was left behind as there has been a drift 
away from the psychoanalytic tradition, but the nosological change has not left a vacuum as 
the phenomenology has remained unchanged.  
The second main reason for this reduced focus is the previously mentioned hierarchical 
system of diagnosis. Embedded in this system lies an assumption that there is a kind of 
etiological hierarchy where you find the “organic psychosis” (meaning psychosis resulting 
from damage at known brain-sites) in one end, followed by the “non-organic” psychosis and 
then mood and anxiety disorders at the opposite end (Freeman and Garety, 2003). Following 
this, research has chose to focus on these states as representing clearly separate conditions.  
Thirdly, the search and belief in a single cause of illness may have hampered the research 
concerning emotional dysfunction in psychosis. According to this hypothesis, there should be 
a single unitary cause underlying all serious disorders, where the other features of the 
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disorder merely represent consequences of the underlying essence of the disorder (Kendler 
et al., 2010). 
Additionally, recent research has emphasised that psychosis is not, in all aspects, 
qualitatively different from normal experiences (van Os et al., 2000;Freeman et al., 2008). The 
symptoms of psychosis occur in normal non-clinical samples. Psychotic symptoms can be 
provoked in otherwise well-functioning individuals when undergoing sensory deprivation. It 
can be triggered by life-events and many patients do show insight into their symptoms and 
difficulties. Moreover, the assumption that psychotic symptoms and the patients reaction to 
these experiences are impossible to understand, has turned out to be wrong (Freeman et al., 
2001). In other words it is possible to understand both psychosis and emotional dysfunction 
in the same psychological framework, and there is no obvious reason to draw a sharp 
distinction between these constructs. For instance, recent research has found support for 
the view that paranoia can be conceptualized as a type of anxious fear (Freeman et al., 
2008). Thus, to be able to have a clear overview when approaching psychotic disorders 
whether it is in the clinic or research settings, we need to link psychology with the biological 
and the social context assuming that these factors will have different levels of explanatory 
power depending on individual differences in vulnerability. 
Studies have demonstrated that depression, low self-esteem and anxiety are not only 
common, but highly correlated with each other in psychosis (Watson et al., 2006;Freeman and 
Garety, 2003). Furthermore, emotional dysfunction has shown to express itself not only 
during the prodromal phase and to be prevalent through the first episode of psychosis, but 
actually manifest itself before psychosis symptom development. Taking this into account, 
the possibility that emotional dysfunction not only accompany psychotic symptoms, but 
actually might influence psychosis, is important. In other words, emotions can be viewed as 
potential contributory factors to both symptom development and maintenance.  
Previous research trying to decipher these relations, has pointed towards the possibility of 
different pathways to emotional dysfunction in psychosis, not necessarily mutually exclusive 
(Birchwood, 2003): 1) emotional dysfunction developing along a disturbed developmental 
pathway, 2) emotional dysfunction intrinsic to the psychosis, and finally, 3) emotional 
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dysfunction as a reaction to the psychotic episode.  Following this theory, each pathway may 
hold some specific factors that exert a pathoplastic effect on the development of emotional 
dysfunction. The papers in this thesis are based on the same theoretical framework. It 
examines further different factors assumed to be of importance for the development of 
emotional dysfunction in psychosis and its associations to other clinical symptoms.  
1.3. Depression 
1.3.1. Definition: Major Depressive Episode-DSM-IV 
According to DSM-IV a Major Depressive Episode (MDE) is characterized by a period of at 
least two weeks during which there is either depressed mood or the loss of interest or 
pleasure in nearly all activities. In addition, the individual must experience at least four of 
the following symptoms; changes in appetite or weight, sleep, and psychomotor activity; 
decreased energy; feelings of worthlessness or guilt; difficulty thinking, concentrating, or 
making decisions; or recurrent thoughts of death or suicidal ideation, plans or attempts. The 
symptoms must be present for most of the day, nearly every day and mark a significant 
difference from the person’s habitual state of mind.  
When a mood disorder such as a MDE is superimposed on a diagnosis of psychotic disorder, 
an additional diagnosis of Depressive Disorder Not otherwise Specified (MDE-NOS) is 
applied.  
1.3.2. Prevalence rates of depression in psychotic disorder 
The prevalence rate of depression in schizophrenia varies widely across published studies 
(from 7-75%), but with an average prevalence rate of 25% (Addington et al., 2002;Hirsch and 
Jolley, 1989;Koreen et al., 1993;Siris, 1991).  These variations are probably due to the wide 
heterogeneity in the study populations with regard to diagnoses, chronicity and assessment 
tools used. Studies of depression in schizophrenia have also been inconsistent since the term 
“depression” could include considerations of the affect, the symptom or the clinical 
syndrome (Gift et al., 1980;Siris, 2000). While discussing depression as an affect, we are 
discussing the individual’s subjective momentary mood state. Even though it might be 
lowered, it is not necessarily pathological if otherwise appropriate for the situation. 
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Depression as a symptom is defined as a sad mood state causing subjective distress. It might 
not be enduring or accompanied by other features of depression. The syndrome is a more 
complex entity consisting of a certain set of symptoms and endurance as previous described. 
The interchangeable use of these expressions without clearly statements about how they are 
defined has blurred this field of research.  
However, few studies have examined depressive symptoms in patients with a first episode 
psychosis.  Häfner and coworkers (Hafner et al., 2005)  studied depressed mood in 232 first 
episode patients with schizophrenia and found that the lifetime prevalence of depressed 
mood at first admission was 83%.  Sim and coworkers (Sim et al., 2004) examined psychiatric 
comorbidity among 79 patients with a first episode psychosis and found that 13 patients 
(16.5%) met the DSM-IV  criteria for a depressive disorder.  Koreen and coworkers (Koreen 
et al., 1993) found  among 70 first episode psychosis patients that the prevalence of 
depressive symptoms  was 75% for meeting the criteria based on either Hamilton Rating 
Scale for Depression scores or the Research Diagnostic Criteria, but only  22% of the patients 
met both criteria. 
1.3.3. Conceptualisation of depression in psychotic disorder 
During the last ten years the acknowledgement that depression might occur in all phases of 
psychotic disorders has led to new theories about possible pathways to depression in line 
with the previously described pathways to emotional dysfunction (Birchwood, 2003); 1) 
Depression as the product of a developmental pathway, 2) depression as intrinsic to the 
psychosis diathesis and 3) depression as a psychological reaction to the psychotic episode.  
The stress-vulnerability model of psychosis which hypothesises that psychosis exists as a 
final common path of neuropsychiatric decompensation can serve to enhance our 
understanding of the developmental pathway (Zubin and Spring, 1977). There are numerous 
factors influencing normal emotional development and functioning. These comprise 
psychological, social and biological factors.  
Traumatic interpersonal experiences and lack of opportunities to develop adequate coping 
skills are examples of psychosocial stressors known to precipitate the development of 
psychosis. High rates of traumatic histories among individuals with a psychotic disorder has 
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been proposed as a precipitating factor (Greenfield et al., 1994). Furthermore, there are now 
clear evidence that social environment such as urban living, deprivation, being member of 
marginalized group, migration and living in the Western world influence both morbidity and 
outcome in psychotic disorder (Harrison et al., 2001). Finally, several biological mechanisms 
could be involved in the development of psychosis, including factors suspected to influence 
normal development such as intrauterine viral infection, poor prenatal nutrition, birth 
injuries and childhood head trauma (Siris, 2000).  
In addition, recent research has discovered probable common genetic risk factors for both 
psychotic and affective disorders (Craddock et al., 2006). To sum up, biopsychosocial risk 
factors commonly known to influence mood and be associated with development of 
depression, have been associated with development of psychosis. 
In the second pathway in which depression is defined as a state integral to the psychotic 
state of mind, depression is understood as a more or less ‘normal’ reaction to the distress 
linked to individual psychotic symptoms. Several studies have pointed to the stress resulting 
from the affect generated by voices such as anger, fear or elation (Chadwick and Birchwood, 
1994;Trower, 2004). In a study of 62 patients, beliefs about the power and meaning of voices 
showed a close relationship with coping behaviour and affect and accounted for the high 
rate of depression in the sample (Birchwood and Chadwick, 1997). Fifty-three per cent were 
at least moderately depressed and 24 % were severely depressed.  Of those who believed 
that their voices were malevolent, 68% were at least moderately depressed, while the same 
figures for those who believed their voices was benevolent was 35%, or benign 47%. Of 
those who believed their voices were very powerful, 60% were at least moderately 
depressed compared with 25% in the group who rated their voices to be powerless. Another 
study focusing on persecutory delusions and accompanying emotional distress, found that 
among 25 individuals with persecutory delusions only four had no significant symptoms of 
depression (Freeman et al., 2002). Higher feelings of control were associated with lower 
level of depression and lower level of delusional distress. Furthermore, there was a trend for 
higher evaluation of the power of the persecutor to be associated with higher levels of 
depression. The same study found that all participants reported use of safety behaviours 
21 
 
assumed to alleviate emotional distress. This is interesting if we view psychosis as arising 
from an interaction between psychotic and non-psychotic experiences (Garety et al., 2001). 
One could imagine that these safety behaviours not only alleviated emotional distress 
caused by the unpleasant thoughts about persecution, but that withdrawal at the same time 
exacerbated depression by isolation and loss of correctional input.  
The third pathway, perceiving depression as the result of a psychological reaction to the 
psychotic episode, has been linked to several factors. The term post psychotic depression 
was described by McGlashan and Carpenter in 1976 (McGlashan and Carpenter, Jr., 1976). It 
comprises factors of possible explanatory power that still constitutes an important 
framework for the understanding of depression revealing itself in the aftermath of the 
psychotic episode. In a dynamic formulation they view post psychotic depression as 1) a 
reaction to the psychosis and a blow to previous self-esteem, 2) a loss of old ways of coping 
and loss of omnipotence in the self and significant others, 3) a symptomatic reaction to 
facing the necessity to change, to individuate, and to take responsibility for one’s own life. 
Research has focused upon related factors such as how insight into illness, perceived 
stigmatisation and appraisal of the psychotic episode might trigger depression in vulnerable 
patients (Birchwood et al., 1993;Iqbal et al., 2000;Karatzias et al., 2007;Yanos et al., 2008). 
The social ranking theory is applied in some of these studies, where the perceived loss of 
status in the social hierarchy as a consequence of the psychotic disorder is followed by a 
feeling of defeat and entrapment which in turn fuels depressive symptomatology (Gilbert 
and Allan, 1998). 
Lastly, there are numerous conditions that have the possibility to mimic or induce 
depression in individuals affected by a psychotic disorder as well as in the general 
population, such as cardiovascular disorders, infections, autoimmune diseases, anaemia, 
cancer and metabolic, neurological and endocrine disorders (Bartels and Drake, 1988). In 
addition various pharmaceutical agents used in the treatment of somatic disorders have 
depression as a known possible side-effect. Neuroleptic-induced depression is a term more 
acknowledged in earlier literature, but worth mentioning. The causal relationship behind this 
theory lies in the involvement of the dopamine synapses in the mesolimbic dopamine 
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reinforcement system or the dopamine reward system. The inhibition of this by a 
antipsychotic drug has been promoted as a contributing factor to symptoms of depression 
and depressive disorder among individuals diagnosed with a psychotic disorder (Harrow et 
al., 1994). However, others have found depressive symptoms to decrease following 
antipsychotic treatment in the acute psychotic phase (Knights and Hirsch, 1981). The 
introduction of second generation antipsychotics with less pronounced dopaminergic 
blockade has further reduced the focus on this relationship. Another important factor that 
might mimic depression is the complex of negative symptoms in psychotic disorder such as 
passive withdrawal, avolition, anhedonia or apathy.  
Gender differences in the prevalence of both schizophrenia and depression have 
consistently been reported. Previous studies in schizophrenia spectrum disorders have 
shown men to have earlier onset, poorer premorbid functioning and different premorbid 
behavioural predictors of psychosis (Leung and Chue, 2000). Women have been shown to 
have more affective symptoms, more self-destructive behaviour and more often troubled 
relationships (Koster et al., 2008;Bardenstein and McGlashan, 1990).  There are also 
differences in the prevalence of depressive symptoms, even though Addington and 
coworkers found that  differences in level of depressive symptoms in males compared to 
females disappeared when diagnostic limits were broadened to include a wider diagnostic 
spectrum and  not restricted to narrowly defined schizophrenia (Addington et al., 2002).  To 
be aware of possible gender differences is of importance since there are clear indications of 
differences in the prevalence and clinical picture of depression in the general population, 
with a higher prevalence and more atypical depressive features in females (Halbreich and 
Kahn, 2007). From a clinical perspective, possible gender differences could imply the need 
for a more gender specific assessment and treatment approach. There are also indications of 
a more significant role of substance use, mainly alcohol, in male depression (Walinder and 
Rutzt, 2001) 
1.3.4. The relevance of depression in psychotic disorder 
Most importantly, depression in psychotic disorder is associated with increased suicidality 
(Drake et al., 1985;Fenton, 2000). A recent reexamination of suicide risk in schizophrenia  
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estimated a lifetime suicide prevalence of nearly 6 % of those observed from first admission 
or onset (Palmer et al., 2005). Furthermore, and maybe more striking, was the fact that 
among first-admission and new-onset samples, 30,6 % of deaths were due to suicide, 
compared to 4,9 % in samples independent of duration of illness. Thus, the risk of suicide is 
most common in the early phases (including the periods before and after onset). This 
highlights the importance of an active approach towards recognition and treatment of 
depression and other factors that might contribute to hopelessness and suicidal ideation.  
Among patients with a psychotic disorder, depression and depressive symptoms have shown 
to be associated with a higher incidence of relapse and rehospitalisation  (Herz and 
Lamberti, 1995). This is not only an economical burden for society, but most importantly an 
additional psychological burden for the patient. In line with this, depression has been linked 
to reduced level of social functioning and reduced  quality of life (Sim et al., 2004). 
Even though depressive symptoms appear to be common among patients with 
schizophrenia spectrum disorders, there is a growing awareness of the fact that depression 
is an underdiagnosed and undertreated comorbid condition in this patient group (Addington 
et al., 2002; Sim et al., 2004), and clinical guidelines are still lacking. 
There is thus a lack of research on depressive symptoms and depression among patients 
with a first episode psychosis. Furthermore, to our knowledge, no previous study examined 
depressive symptoms at start of treatment. Thus, further knowledge about the prevalence, 
developmental factors and time course of depression in relation to psychotic symptoms is 
needed.  More information about factors that influence the rate or severity of depressive 
states would also aid the development of clinical guidelines on treatment of depression in 
schizophrenia (Addington et al., 2002). 
1.4. Social anxiety disorder 
1.4.1. Definition: Social anxiety disorder-DSM-IV 
Social anxiety disorder as described in DSM-IV is characterized by a marked and persistent 
fear of  social interaction or social performance situations in which embarrassment may 
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occur (American Psychiatric Association, 1994). Exposure to a feared situation almost 
inevitably provokes an immediate anxiety response, even though the individual recognizes 
that the fear is excessive or unreasonable. Individuals suffering from social anxiety tend to 
avoid the anxiety provoking situations. The diagnosis is appropriate only if the anxiety 
symptoms interfere significantly with the persons daily routine, occupational functioning or 
social life, or if the person is markedly distressed by the anxiety disorder. The disorder 
should not be better accounted for by another mental or medical condition. If the individual 
has another condition, the fear and avoidance is not limited to concern about its social 
impact. Social anxiety disorder typically has an onset in the mid-teens and can be preceded 
by a childhood history of social inhibition and shyness. Later onset can be characterized as 
abrupt, typically after a stressful or humiliating situation. The course is often continuous and 
the individual becomes trapped in a viscous circle where the pattern of avoidance behaviour 
prohibits opportunities for recovery by gaining positive experiences and a sense of mastery. 
Generalized social anxiety disorder: The term is applied if the fears include most social 
situations as initiating or maintaining conversations, participating in small groups, dating, 
speaking to authority figures, attending parties. People suffering from generalized social 
anxiety disorder usually fear both public performance situations and social interaction 
situations. Furthermore, they will be more likely to manifest deficits in social skills and to 
experience severe social and work impairment.  
1.4.2. Prevalence rates of social anxiety in psychotic disorder 
Social anxiety disorder is considered to be one of most prevalent anxiety disorder in 
schizophrenia. A meta-analysis by Achim and coworkers (Achim et al., 2009) showed pooled 
overall prevalence rates for social anxiety disorder in schizophrenia to be approximately 
15%. Others have found it to vary from 14% to 39 % between different studies (Cosoff and 
Hafner, 1998;Pallanti et al., 2004;Bermanzohn et al., 2000;Cassano et al., 1999).  
1.4.3. Conceptualisation of social anxiety in psychotic disorder 
Even though there has been an increasing interest in research focusing on anxiety symptoms 
in psychotic disorders, the understanding of how anxiety disorders are related to different 
aspects of psychotic disorders still remains unclear (Braga et al., 2004).  Reviewing the 
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literature, the three possible pathways previously described to explain development of 
emotional dysfunction, have been applied to enhance the understanding of social anxiety in 
psychotic disorder (Birchwood et al., 2006;Voges and Addington, 2005;Gumley et al., 2004a); 
1) Social anxiety as a pre-morbid developmental disorder and a vulnerability marker for 
schizophrenia 2) Social anxiety as a core component of the psychotic syndrome, and 3) Social 
anxiety emerging as a psychological reaction to the psychotic episode.  
Concerning the first possibility, social anxiety evolving through a developmental pathway to 
psychosis, the Edinburgh High-Risk Study found early “situational anxiety” to be one of the 
best predictors of conversion to psychosis in a high-risk group with two or more relatives 
with a history of psychosis (Johnstone et al., 2005;Owens et al., 2005). The social withdrawal 
factor concerned with anxiety and introversion was found to be the strongest predictor in 
their assessments, more important than psychotic-like experiences. It has to be noted that 
these individuals were non-psychotic on entry into the study. Contrary to this, Hafner et al. 
did not find any indications in their study that individuals diagnosed with schizophrenia were 
inferior in social status compared to age and gender matched controls from the general 
population prior to the development of a psychotic disorder (Hafner et al., 1999). 
Furthermore, Birchwood et al. failed to find any differences in premorbid peer-relations in a 
group of first episode patients with social anxiety disorder compared to first episode 
patients without social anxiety disorder (Birchwood et al., 2006). They concluded that the 
group with social anxiety disorder might have had a latent premorbid anxiety acting as a 
vulnerability marker for developing social anxiety as a reaction to the psychosis. To our 
knowledge, no study has explicitly made any effort to explore this further and to what extent 
premorbid functioning interacts upon the development of social anxiety in psychotic 
disorders is still unclear.  
Concerning the second possible pathway, studies have found support for the view that social 
anxiety is a core component of the syndrome, or at least a co-occurring process that might 
both initiate and exacerbate positive psychotic symptoms (Freeman et al., 2008). Several 
studies have repeatedly found anxiety to be associated with paranoid thoughts and 
persecutory delusions (Startup et al., 2007;Martin and Penn, 2001;Freeman et al., 
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2001;Lincoln et al., 2009). A central idea in this theory is that delusions are false positive 
beliefs that are held with a certain degree of conviction. As beliefs are linked to emotions, 
these beliefs will consequently convey anxiety if the idea represents a threat to the 
individual. Fear of negative evaluation is central to social anxiety and represents a threat to 
the individuals self. Hence, the idea that threat in the context of social anxiety and in 
persecutory delusions may share common predictors is quite plausible as the threat content 
can be quite similar. Pallanti and coworkers (Pallanti et al., 2004) found no relationship 
between positive or negative symptoms and social anxiety, while others again have found 
social anxiety to be related to negative symptoms only, and not to positive symptoms (Voges 
and Addington, 2005). The last finding is intriguing from a cognitive approach. As safety 
behaviour is commonly used to reduce perceived threat in both persecutory delusions and 
social anxiety, there is a risk of mislabelling social anxiety as negative symptoms.   
The third pathway perceives social anxiety as a result of the psychotic episode. Embedded in 
this theory lies the individuals appraisals of psychosis involving loss of social role, shame and 
enforced low status (Iqbal et al., 2000). A negative appraisal of psychosis and self has also 
been associated with post-psychotic depression. Iqbal and coworkers explained this in terms 
of depressogenic life events (Iqbal et al., 2000). Certain events are more likely to enhance 
depression than others, especially if they comprise feelings of loss, humiliation and 
entrapment. There are findings supporting this by demonstrating that individuals with 
psychosis and a concurrent social anxiety disorder, exhibit more negative beliefs about 
psychosis and have lower levels of self-esteem than controls without social anxiety disorder 
(Gumley et al., 2004b). There are several studies showing that particularly schizophrenia 
carries severe stigma and that there is a tendency to internalise these stigma with 
subsequent development of shame and reduced self-esteem (Birchwood et al., 
1993;Corrigan and Watson, 2002). Hence, implicit in this third pathway, is the assumption 
that social anxiety has to be linked to a certain degree of insight into illness for these 
processes to take place. There are only few studies trying to explore this relationship 
between social anxiety and insight into illness, but they have found this association to be 
present (Birchwood et al., 2006;Iqbal et al., 2000). 
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1.4.4. The relevance of social anxiety in psychotic disorder 
The importance of focusing on social anxiety disorder among patients with psychosis is 
apparent. Despite the previously described difficulties in conceptualising social anxiety in 
this context, it has been demonstrated that important outcome measures are clearly related 
to social anxiety.  
Firstly, a close relationship between social anxiety disorder and poorer quality of life  
(Pallanti et al., 2004) has been revealed in patients with a longer duration of illness. This is in 
line with findings in a previous review, pointing to the fact that major determinants of 
subjective quality of life in people with severe mental illness is the level of psychopathology, 
especially anxiety and depression (Hansson, 2006). Taking into account that social anxiety 
has been reported to be the most frequently occurring co-morbid disorder with depression 
(Stein et al., 1990) and seems to precede depression  in the general population (Kessler et 
al., 1999;Stein and Chavira, 1998), this is not a surprising finding. However, compared to the 
general population, the raised suicide rate in psychotic disorders underlines the importance 
of focusing on factors known to contribute to depression (Melle et al., 2006). Furthermore, 
previous studies have demonstrated that social anxiety seems to inhibit help-seeking 
behaviour for depression (Pilkonis et al., 1980). 
Secondly, social anxiety has been associated with poorer social functioning in schizophrenia 
(Blanchard et al., 1998). This was supported by a study by Pallanti et al. who found 
significant impairment in three of five areas of adjustment when they compared patients 
with schizophrenia with and without social anxiety; work/job, socialization, and personal 
well-being (Pallanti et al., 2004). Both samples consisted of patients with a long history of 
psychosis. Only a few studies of first episode psychosis have addressed this problem. Voges 
and Addington examined this relationship and found  a strong association between social 
anxiety and social functioning (Voges and Addington, 2005). Another study found first 
episode patients with social anxiety to be more actively withdrawn than patients without 
comorbid social anxiety (Birchwood et al., 2006). More research is warranted as social 
functioning is important to enhance quality of life and the ability to adapt to society in 
general, which at present is a major obstacle for the majority of these patients. 
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To sum up, these three pathways constitute a reasonable theoretical framework for 
understanding the development of social anxiety in psychosis, but more studies are 
warranted as the underlying mechanisms are still unclear. There are clear advantages of 
studying patients with early psychosis. It implies reduced possibility of persecutory thinking 
and social anxiety blending up due to chronicity, and a reduced recall bias with regard to 
premorbid functioning. However, few studies have been performed among first episode 
psychosis patients (Birchwood et al., 2006;Voges and Addington, 2005;Michail and 
Birchwood, 2009). 
1.5. Self-esteem   
1.5.1. Definition and relation to DSM-IV 
Self-esteem is a complex concept, comprising appraisal of self- worth based on personal 
achievements and anticipation of evaluation by others. A search of the DSM-IV-TR revealed 
that the term-self-esteem appears in 24 diagnostic contexts, as a criterion for disorders, as a 
criteria for disorders being considered for inclusion in future DSM editions and as an 
associated feature of disorders (Kernis, 2005). Despite the relatively clear associations 
between self-esteem and a vast array of psychopathological conditions (Silverstone, 1991), 
the precise role of self-esteem still remains blurred.  
Reviewing the literature on self-esteem while exploring the different definitions applied in 
previous studies, confirms the complexity of this field. Morris Rosenberg defined self-esteem 
in terms of  the individual’s positive or negative attitude toward the self;  “When we speak of 
high self-esteem, then, we shall simply mean that the individual respects himself, considers 
himself worthy; he does not necessarily consider himself better than others, but he 
definitely does not necessarily consider himself worse; he does not feel that he is the 
ultimate in perfection but, on the contrary, recognizes his limitations and expects to grow 
and improve. Low self-esteem on the other hand, implies self-rejection, self-dissatisfaction, 
and self-contempt. The individual lacks respect for the self he observes. The self-picture is 
disagreeable, and he wishes it otherwise” (Rosenberg, 1989).   
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This definition describes global self-esteem which develops over time. Furthermore, 
Rosenberg made distinctions between what he called barometric and baseline instability 
(Rosenberg, 1986). With baseline instability he meant long-term fluctuations in ones self-
esteem that gradually changes over a longer period of time. As an example he pointed to 
decreases in self-esteem level that are common in children as they move from the relatively 
secure stability of the elementary school to the more insecure environment in the middle 
school. This decrease is followed by a slow but steady increase in self-esteem through the 
high-school years. In contrast, barometric instability reflects the short term fluctuations in 
ones contextually based global self-esteem.  
Even though Rosenberg described instability as an essential component of the construct of 
self-esteem, this has been taken further by theorists such as Michael Kernis. He elaborates 
on Rosenbergs approach by accepting that global self-esteem is a reflection of the 
individual’s representation of how he typically feels about himself across time and context 
(Kernis, 2005). This, he calls level of self-esteem. However, as a contrast to this, he 
introduces the term self-esteem stability which refers to the magnitude of short-term 
fluctuations that people experience in their contextually based immediate feelings of self-
worth. This is not measureable with global measures of self-esteem, but is typically 
measured by instructions to base their responses on “how they feel at the moment”. 
Crocker and Wolfe on the other hand, have defined global self-esteem as a model in which 
people have a typical, or average, trait level of self-esteem, but where their momentary or 
state level of self-esteem will be fluctuating around this trait level based upon the 
individuals’ contingencies of self-worth (Crocker and Wolfe, 2001). As an example, some 
people will base their self-worth on their ability to make people laugh, while other will base 
it on their mathematical skills. Most people hold multiple contingencies of self-worth, and 
they may hold them in varying degree. It is the person's interpretation of the event or 
circumstance, and its relevance to his or her contingencies of self-worth, that determines 
both if and how strongly an event will inform judgements of overall self-worth or global self-
esteem (McFarland and Ross, 1982;Crocker and Wolfe, 2001).  
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1.5.2. Self-esteem and psychiatric conditions 
Even though not uniformly low, self-esteem is  often found to be compromised among 
persons with mental illnesses (Van Dongen, 1996).  Low self-esteem is of considerable 
interest because it is both a possible consequence and a cause of psychiatric symptoms 
(Greenberg et al., 1992;Karatzias et al., 2007;Blairy et al., 2004). In line with this, studies 
show that stigmatization and self-stigmatization may lower self-esteem in persons with 
mental illness (Link et al., 2001).  On the other hand, low self-esteem also appears to 
increase the risk of psychiatric disorders such as depression, eating disorders and substance 
abuse (Silverstone and Salsali, 2003).   
1.5.3. Self-esteem and psychotic disorder 
In psychotic disorders, low self-esteem has been implicated both in the development of 
delusions (Bentall et al., 2001;Barrowclough et al., 2003) and the maintenance of psychotic 
symptoms (Garety et al., 2001).  
How treatment failures, functional loss, demoralization and stigmatization may lower self-
esteem in patients with severe mental illnesses appears evident.  However, to what extent 
low levels of self-esteem in severe mental disorders could be based on factors predating the 
onset of psychosis, and how this in turn may increase vulnerability to more severe 
symptoms, has not been thoroughly explored.    
One would assume that people’s global level of self-esteem would be affected by 
experiences in early childhood and adolescence. In line with this, studies have suggested 
that difficult childhood experiences such as childhood loss and social marginalization 
contribute to a cognitive vulnerability accompanied by a negative view both towards the 
person himself and towards others (Greenberg et al., 1992;Birchwood, 2003;Garety et al., 
2001). Based on this, one could hypothesize that individuals with a history of poor 
premorbid adjustment (both social and academic) could be more prone to negative self-
evaluation and reduced global self-esteem. To our knowledge only one study has examined 
the relationship between premorbid adjustment and self-esteem in patients with 
schizophrenia spectrum disorder (Gureje et al., 2004). They found no relationships between 
self-esteem and premorbid adjustment in recovered psychotic patients. However, 
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premorbid adjustment was not captured with a specific instrument, a factor that may 
account for the negative results. 
There is a vast body of literature on the relationship between low self-esteem and symptom 
formation in severe mental disorders, both psychotic and affective disturbances. Bowins and 
Shugar found that the contents of patients’ delusions were consistent with patients’ global 
self esteem, and suggested that low self-esteem accounted for the persistence of delusions 
(Bowins and Shugar, 1998).  Barrowclough and colleagues found a  significant correlation 
between negative self-evaluation and a wider variety of positive symptoms (hallucinations 
and delusions) in schizophrenia (Barrowclough et al., 2003), while Smith and coworkers 
found that patients with a low level of self-esteem and more depressive symptoms had more 
intense auditory hallucinations with more negative content (Smith et al., 2006).  
Other studies have, contrary to this, found higher levels of self-esteem in patients with 
delusional disorder compared to depressed patients (Candido and Romney, 1990). However, 
they found that the group without depressive symptoms had significantly higher levels of 
grandiose ideations than the other groups, which may account for the elevated levels of self-
esteem. The authors concluded that persecutory delusions may reflect an attributional style 
protecting the individual from low self-esteem. Other studies have found equal levels of self-
esteem in patients with delusions and matched healthy controls with  both groups 
demonstrating  higher levels than depressed patients (Lyon et al., 1994). Finally, others have 
found that self-esteem acted independently in contributing to depression in psychosis 
(Fannon et al., 2009). 
Hence, even though there are indications for an association between psychotic symptoms 
and self-esteem, there are still uncertainties regarding the direction of previous findings. Is 
the reduced self-esteem a result of the psychotic disorder, or was self-esteem reduced 
before the onset of psychosis? If self-esteem was reduced even before onset of psychotic 
symptoms, one possible factor to mirror this relationship would be premorbid adjustment, 
particularly premorbid social adjustment as this could be related to low self-esteem. This is 
of importance in order to understand the mechanisms behind the development of psychotic 
symptoms, and to improve treatment as self-esteem can be influenced by therapeutic 
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interventions such as cognitive behavioural therapy for psychosis (Hall and Tarrier, 
2003;Hodgekins and Fowler, 2010).Previous studies on the relationship between premorbid 
adjustment, low self esteem and positive symptoms have all included patients with chronic 
psychotic disorders, where the effects of a long-term severe illness may significantly 
confound relationships. To our knowledge, no previous studies have examined these 
relationships in patients coming to their first treatment for a psychotic disorder with less 
prominent effects of treatment failures and subsequent disappointments.  
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2. AIMS OF THE THESIS 
The overall aim of the thesis was to gain more knowledge about emotional dysfunctions in 
the early phase of psychotic disorders.  
Paper I 
In paper I we aimed to describe the time course of lifetime SCID-I verified Major Depressive 
Episode (MDE) in first episode psychosis and examining differences in demographic and 
clinical characteristics between patients with and without a lifetime history of MDE. Finally 
we wanted to examine how different patient characteristics were associated with current 
level of depressive symptoms. An emphasis was put on gender differences. 
Paper II 
In paper II we aimed to investigate to what extent premorbid adjustment is related to self-
esteem  in first episode psychosis, to what extent self -esteem is related to the level of 
hallucinations and finally, we explored to what extent self-esteem is related to the level of 
delusions in general and persecutory delusions in particular. 
Paper III 
In paper III we aimed to validate the Liebowitz social anxiety scale (self-rated version) in a 
first episode psychosis sample. Finally, we explored the role of self-esteem as a possible 
predictor of social anxiety while adjusting for current level of delusions, suspiciousness and 
depression.  
Paper IV  
In paper IV we aimed to investigate whether first episode patients with high levels of current 
social anxiety symptoms revealed poorer premorbid functioning and stronger associations to 
clinical correlates such as current psychotic symptoms and depression. Furthermore we 
wanted to explore if they had lower levels of current functioning, better insight and lower 
self-esteem than patients with no or minor symptoms of social anxiety. Finally, we wanted 
to explore if social anxiety per se was a possible independent predictor of quality of life. 
34 
 
3. METHODS 
3.1. Design 
The present thesis is based upon data from the Thematically Organized Psychosis (TOP) 
Study, which is a large ongoing translational research study. The design of the current study 
is naturalistic and cross-sectional with focus on first episode psychosis patients. The overall 
aim of the TOP study is to investigate clinical and biological characteristics of schizophrenia 
spectrum and bipolar disorders in order to gain more knowledge about underlying 
pathoplastic factors. Clinical and neurocognitive data has been collected, along with data 
from functional and structural MRI and genetic information. The study is affiliated with the 
University of Oslo and Oslo University Hospital (including three of four psychiatric units in 
Oslo). Furthermore, there are participants from two neighbouring counties and one unit in 
mid-Norway, Innlandet Hospital Trust. All clinical participants were recruited consecutively 
from both in-patient and out-patient units. The Norwegian catchment area patient 
admittance system allows for a high degree of patient representativity, as all people are 
offered public mental health care when needed within a given catchment area.  
3.2. Material 
The TOP-study has aimed at including all consecutively admitted patients with a psychotic 
disorder in treatment at any of the connected hospitals. Inclusion to the TOP-study started 
late 2002, and the inclusion process is still running. To be eligible for inclusion, the patients 
had to be aged between 18 and 65 years, have a DSM-IV diagnosis of psychotic or bipolar 
disorder or major depression with mood incongruent symptoms. Exclusion criteria were; 
having an IQ below 70, history of serious brain damage, a diagnosis of a developmental 
disorder or not being able to speak nor understand Norwegian language. All patients were in 
treatment and were referred from their main clinician. Emphasis was put upon the ability to 
give informed consent before inclusion to the project.  
The study samples in the present thesis comprised three partly overlapping samples of first 
episode psychosis patients recruited to the TOP-study (see Appendix 2. for an overview of 
the different samples). First episode patients were defined as patients being treated with 
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antipsychotic medication in adequate dosage for less than a year, and if being treated 
previously, not treated more than 12 weeks or until remission. The sample described in 
paper I mostly consists of individuals included at an earlier time point than the samples 
represented in paper II-IV. These patients are recruited from the hospitals in Oslo County 
and the two neighbouring counties that at the given time point were connected to the TOP-
study. A hospital representing mid-Norway, Innlandet Hospital Trust, was connected to the 
general TOP-study during the inclusion period. Their contribution is reflected in paper II-IV as 
will be discussed later. 
The number of patients in each sub-study was selected depending on whether they had 
been assessed with specific assessment tools found relevant to answer the chosen research 
questions represented by the four papers. In paper I, 122 patients had been assessed with 
the Calgary Depression Scale for Schizophrenia (CDSS), in paper II 113 had been assessed 
with the Rosenberg Self-Esteem Scale (RSES), in paper III and IV , both comprising the same 
sample, 144 had been assessed with the Liebowitz Social Anxiety Scale (LSAS-SR).  There are 
several reasons why the samples are only partly overlapping. The RSES and the LSAS-SR were 
added to the study protocol at a late stage of inclusion to the TOP-study. Data for paper I 
was thereby drawn from an earlier population. Regarding the RSES, one of the inclusion sites 
missed adding this form into their protocol. This was discovered at a later stage, and the 
form was then added. Unfortunately, this reduced the number of subjects available for 
analysis in paper II. The samples in paper III and IV are identical. 
In paper I and II, patients with Major depression with mood incongruent symptoms as their 
primary diagnosis were not included. Paper I explores depression as a comorbid symptom 
dimension, and as such the inclusion of individuals with depression as their primary 
diagnosis did not seem appropriate. The strong association between a primary diagnosis of 
depression and lowered self-esteem was the basis for exclusion in paper II, where the main 
focus was upon self-esteem in psychotic disorder. 
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3.3. Measures 
3.3.1. Diagnostic assessment 
Diagnosis was based on the Structured Clinical Interview for DSM-IV Axis I Disorders (First et 
al., 1995), modules A-E. The patients were interviewed by trained psychologists and 
psychiatrists who were regularly supervised during diagnostic consensus meetings led by 
Professor in Psychiatry Stein Opjordsmoen, a clinically well experienced investigator.  
Furthermore,  all the interviewers had completed the general training- and reliability 
program in the TOP research study based on the training program at the UCLA (Ventura et 
al., 1998). For DSM-IV diagnostics, mean overall kappa with training videos was 0.77, and 
mean overall kappa for a randomly drawn subset of actual study patients was also 0.77 (95% 
CI 0.60-0.94).  
3.3.2. Clinical assessment 
Current psychotic symptom level was rated using the Structural Clinical Interview of the 
Positive And Negative Symptom Scale (SCI-PANSS) (Kay et al., 1987). Inter-rater reliability, 
measured by the intra class correlation coefficient (ICC 1.1), were for the PANSS positive 
subscale was 0.82 (95% CI 0.66–0.94), for the PANSS negative subscale 0.76 (95% CI 0.58–
0.93), the PANSS general subscale 0.73 (95% CI 0.54–0.90). Current psychosis was defined as 
a score of 4 or higher on any of the following PANSS items: P1, P3, P5, P6 or G9.  
Global symptoms and psychosocial functioning were measured by the Global Assessment of 
Functioning Scale (Jones et al., 1995). We applied the split version(Pedersen et al., 2007). It 
distinguishes between symptom level (GAF-S), the overall degree of present symptoms, and 
function level (GAF-F), which focus on the overall degree of social and occupational 
functioning. Inter-rater reliability, measured by the intra class correlation coefficient (ICC 
1.1), for the GAF symptom scale was 0.86 (95% CI 0.77–0.92) and for the GAF functioning 
scale was 0.85 (95% CI 0.76–0.92). Higher scores indicate fewer symptoms and better 
functioning. 
Premorbid adjustment was measured with the Premorbid Adjustment Scale (PAS) (Cannon-
Spoor et al., 1982). The premorbid phase is defined as the time from birth until 6 months 
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before onset of psychosis. It measures both social and academic functioning during four age 
ranges. We only included the age range of childhood (-11 years) and early adolescence (12–
15 years) as the usual onset of schizophrenia spectrum disorders is in early adulthood. We 
thus tried to avoid ‘contaminating’ the premorbid period as it can be difficult to identify the 
exact time point of conversion to psychosis, especially in individuals with insidious onset. To 
make ratings on items regarding sociability and withdrawal, peer relationships, academic 
performance and adaptation to school, information was collected within each age range 
based on information from the patient, medical journal and significant family members, 
when appropriate. Increasing scores indicate poorer functioning. In paper I we used the 
mean score of the sub measures of the PAS, and in paper II and IV, we used the total sum 
score of the PAS sub measures. 
Duration of untreated psychosis (DUP) was measured following the criteria described by 
Larsen et.al (Larsen et al., 1998); time from the first onset of positive psychotic symptoms 
(the first week with a PANSS score of 4 or above on at least one of the Positive Scale items 1, 
3, 5, 6 or General scale item 9) to the start of first adequate treatment of psychosis. 
Current severity of depressive symptoms was assessed using the Calgary Depression Scale 
for Schizophrenia (CDSS) (Addington et al., 1990). Number of lifetime MDE was defined 
according to SCID-I. We registered MDE up until one year before the recorded onset of the 
first psychotic episode as MDE with onset before psychosis, and MDE with onset within the 
same year or after the onset of the first episode as MDE with simultaneous onset or onset 
after psychosis.  
Self-esteem was assessed using the Rosenberg self-esteem scale (RSES) (Rosenberg, 1965). 
This is a 10-item self-administered questionnaire with a 4-point likert-type response set, 
ranging from strongly disagree to strongly agree. 
Social phobia was assessed using the self-rating version of the Liebowitz Social Anxiety Scale 
(LSAS-SR). The LSAS comprise 24 items measuring fear and avoidance separately for 24 social 
situations over the past week. We chose the same way to instruct the patients abut how to 
fill in the questionnaire as described by Fresco et al. (Fresco et al., 2001). 
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Insight was measured by the Insight Scale (Birchwood et al., 1994) and includes three 
dimensions of insight; ‘awareness of illness’,’ awareness of symptoms of psychotic illness’ 
and ‘belief in need for treatment’.  
The Alcohol Use Disorders Identification Test (AUDIT) (Saunders et al., 1993) was used to 
screen for problem drinking , and use of illegal drugs was assessed with Drug Disorders 
Identification Test (DUDIT) (Berman et al., 2005).  
3.4. Literature search 
To get an overview of relevant literature, a thorough search was performed during the early 
phases of this PhD work. With assistance from librarians at the Medical Library at Oslo 
University Hospital-Ullevaal, searches were performed in databases such as PubMed, 
Medline and Psychinfo on the topics depression, self-esteem and social anxiety (and 
interchangeable expressions) in relation to psychosis or schizophrenia. During the research 
period, regularly searches have been performed to check up on recently published relevant 
publications. Bibliographies from important papers have been checked for relevant 
supplements. Hopefully, we have covered the most important literature concerning the 
topics discussed in this thesis.  
3.5. Statistics 
All data were analysed using the Statistical Package for the Social Sciences (SPSS Inc., 
Chicago, IL, USA, version 16.0). Preliminary analyses were performed to examine the 
distribution of each variable which included inspection for skewness, linearity and outliers. 
Only the duration of untreated psychosis (DUP) required transformation to its natural 
logarithm (Ln(DUP+1)), due to skewed data distribution. The five factor model of the PANSS 
scale (Bentsen et al., 1996) was used in paper I, III and IV. Descriptive statistics for the whole 
sample were obtained using proportions, standard deviations, means, medians or range 
according to the measurement type and distribution. Independent sample t-tests were used 
to assess potential differences between groups on demographic and symptom variables. 
Pearson correlation coefficients were used to show how the variables were associated 
within the groups. Significance level was set to p < .05; all tests were two-tailed. Differences 
between multiple groups in normally distributed continuous variables were analyzed with 
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factorial One-Way Analysis of Variance (one-way ANOVA) with post-hoc Tukey tests.  
Hierarchical multiple linear regression analysis was performed to control for possible 
confounders and explore the proportion of variance explained for continuous variables. 
Psychometric properties of the LSAS-SR were analyzed using principal component factor 
analysis with Varimax rotation.  
Further information about the analysis of the different sub studies has been thoroughly 
described in each paper, and the reader is referred to these for more detailed information.  
3.6. Ethical aspects 
3.6.1. The participants perspective 
The TOP-protocol is an extensive and time-consuming protocol including diagnostic 
interviews, neurocognitive tests, blood/urine sampling, somatic testing and can include brain 
imaging. The total evaluation time was several hours and in most cases had to be divided 
over several days. Despite this, the time used for this thorough diagnostic evaluation was 
not considered much longer than what is common in a normal clinical setting, but resulted in 
a more extensive report than usual. The burden for each patient was therefore considered 
to be acceptable, which is very important for research including participants with severe 
mental disorders. To alleviate the stress following the extensive interviews and tests, the 
participants were frequently asked if they wanted a break or would like to continue another 
day.  They were welcomed to bring someone with them to the tests and interviews if they 
felt more secure and less stressed by doing so. The final report was sent to the clinician who 
was in charge of the participants’ treatment, if this was agreed upon. The participant could 
also ask the investigators to withhold certain information he/she did not want the clinician 
to know about regarding drug/alcohol abuse. This was to ensure that the participants felt 
free to admit if they had problems with drugs/alcohol that had been denied in treatment 
settings.  
The impression was that most of the participants appreciated the long time the investigators 
had to talk with them about their problems compared to the time limited appointments in a 
normal clinical setting. Both normalization and psycho-education was extensively used 
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during the interview which often resulted in positive feed-back from the patients. There 
were, however, a few patients who expressed feeling disappointed after receiving their 
diagnosis, and argued that they were misunderstood etc. In such cases, an extra effort was 
made to thoroughly explain the basis for the conclusion. My personal opinion in these cases 
was that reactions like this were connected to the specific diagnosis of schizophrenia, and 
stigma surrounding this diagnosis. I found it helpful to discuss the continuum-hypothesis 
with these patients and be very careful to check out their specific beliefs about having a 
diagnosis of schizophrenia. Furthermore, they were once more informed about their right to 
have all data deleted and refuse to further participate in the study.  
The project was approved by the Regional Ethics Committee (ref # 493-03-01179). 
3.6.2. Data collection and handling 
Written informed consent was obtained before entry to the study. Information about the 
study and the procedure was given both written and orally by a trained MD or psychologist 
well aware of the importance of doing this properly as some degree of cognitive difficulties 
can be present in some of these patients. Included in the information was the purpose of the 
study, extent of investigation and interviews, how and for how long personal information 
would be stored, and how confidentiality would be maintained. They were also informed 
about their right to see all data collected in their name, and have these deleted on any 
request. Furthermore, it was stressed that this was a voluntary project, and that refusal 
would not have any consequence for their future treatment or right to be diagnostically 
evaluated in their usual clinical setting.   
The collecting and handling of data were approved by the Norwegian Data Protection 
Agency (ref # 2003/2052). The TOP database was inspected and approved by the Clinical 
Monitor at Oslo University Hospital (Ullevål) (Audit certificate 12.03.07). Personal 
information was handled following the same rules as applied within the EU countries 
medical system. The only persons with access to personal information will be health care 
professionals with a duty of confidentiality. A numerical code replaced all personal 
identifiers when handling the data. The key to this code was kept separate from the archive 
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and was stored at a similar security level as the ordinary patient data elsewhere in the 
hospital system. 
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4. RESULTS/SUMMARY OF PAPERS 
Paper I: Depression and depressive symptoms in first episode psychosis. 
Objective: The main aim of the present study was to examine the prevalence and pattern of 
lifetime DSM-IV Major Depressive Episodes (MDE), and the relationship between patient 
characteristics and current depressive symptoms in first episode psychosis patients.  
Method: A total of 122 First episode psychosis patients were included. Current severity of 
depression was measured by the CDSS, psychotic symptoms were assessed by the PANSS 
and premorbid functioning was assessed by the PAS. Furthermore, assessment of alcohol 
and drug patterns was measured with the AUDIT and DUDIT and functioning by the GAF.  
Results: A total of 58 patients (48 %) had experienced one or more MDE. Twenty-seven 
(22%) patients had experienced recurrent MDE. There were no differences between the 
groups having a lifetime history of MDE and the group who did not on demographic 
variables. On clinical variables such as GAF, PAS or PANSS the only difference was found in 
the depressive factor score of the PANSS. Twenty-five (21%) patients met the criteria for a 
MDE at the time of inclusion. Furthermore, 21 (17 %) patients had met the criteria for an 
MDE before onset of psychosis and 37 (30 %) during or after onset of psychosis, and 
significantly more females than males (13(30%) vs. 8(10%)) (p= 0.01) had experienced a MDE 
before onset of psychosis. Poor premorbid adjustment in childhood, substance abuse and 
excitative symptoms at start of treatment were significantly associated with higher current 
depressive symptoms. Gender, AUDIT and PANSS excitative symptoms explained a 
significant proportion of the variance in the CDSS scores for the total sample. Divided by 
gender, alcohol use predicted current depression in men, while excitative symptoms were 
predictive of current depression in women in the final model.  
Conclusion: Depressive symptoms are frequent among patients with a first episode 
psychosis and in many cases; these symptoms seem to predate the first episode of 
psychosis. Furthermore, this study indicates that there may be gender specific factors 
associated with the development of depression in psychosis.  
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Paper II: Self-esteem is associated with premorbid adjustment and positive psychotic 
symptoms in first episode psychosis. 
Objective: Self-esteem is often found to be compromised among persons with mental 
illness. Furthermore, low levels of self esteem have been implicated as both a cause and 
consequence of severe mental disorders. The main aims of the study were to examine 
whether poor premorbid adjustment was associated with lowered self-esteem and whether 
lowered self-esteem was found to contribute to the development and persistence of 
delusions and hallucinations in our model. 
Method: A total of 113 patients were included at first treatment. The PANSS was used to 
assess present psychotic- and general symptoms. Premorbid adjustment was measured with 
the PAS and self-esteem by the RSES. Current depression was diagnosed according to the 
criteria for DSM-IV.  
Results: Self-esteem was significantly associated with the four submeasures of PAS 
(childhood and early adolescence social and academic score), hallucinations, persecutory 
delusions and depression. Furthermore, females reported lower self-esteem than males. A 
hierarchical multiple regression analysis with self-esteem as the dependent variable revealed 
that gender and early adolescence premorbid social adjustment contributed significantly to 
the explained level of global self-esteem in the final model. They explained respectively 16% 
and 9% of the variance in self-esteem. A second set of hierarchical multiple regression 
analyses with positive psychotic symptoms as the dependent variables, revealed that self-
esteem explained a significant amount of the variance in hallucination and persecutory 
delusions; respectively 11 % in hallucinations (p3) and 7 % in persecutory delusions (p6). This 
was after controlling for age, gender and depression. 
Conclusion: The current study revealed a significant association between self-esteem and 
premorbid adjustment, especially social adjustment. Furthermore, we found an association 
between poor self-esteem and higher level of positive psychotic symptoms, namely 
hallucinations and persecutory delusions. Both main findings are of importance when 
evaluating possible treatment approaches. Firstly, if self-esteem is linked to poor premorbid 
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adjustment, a more active approach towards increasing self-esteem in adolescence would be 
of interest from a preventive point of view. Furthermore a more targeted  treatment 
approach towards increasing self-esteem by therapeutic interventions in first episode 
patients may possibly  reduce psychotic symptoms.  
Paper III: Assessment of social anxiety in first episode psychosis using the Liebowitz social 
anxiety scale as a self-report measure. 
Objective:  Social anxiety is a common problem in psychotic disorders. The Liebowitz Social 
Anxiety Scale, Self-Rating version (LSAS-SR) is a widely used instrument to capture different 
aspects of social anxiety, but its psychometric properties has not been tested in this patient 
group. The aims of the present study were to evaluate the psychometric properties of the 
LSAS-SR in patients with first episode psychosis, to investigate whether it differentiated 
between active and passive social withdrawal and to test which clinical factors contributed 
to current level of social anxiety. 
Method: A total of 144 patients were included at the time of first treatment. Psychotic and 
general symptoms were assessed by the PANSS, while depression additionally was measured 
by the CDSS. Self-esteem was assessed by the Rosenberg self-esteem scale and finally, social 
anxiety was measured by the LSAS-SR. To validate the psychometric properties of the LSAS-
SR, a factor analysis was carried out and the relationship of social anxiety to psychotic and 
general symptomatology was evaluated.  Possible predictors to social anxiety were analyzed 
using multiple hierarchic regression analysis. 
Results: The Fear and Avoidance subscales turned out to be strongly correlated and loaded 
on the same factor. For the subsequent factor analysis, only the fear subscale was used. The 
factor analysis identified three subscales accounting for 56% of the variance; Public 
performance, Social interaction and Observation. All three subscales showed satisfactory 
psychometric properties, acceptable convergent and discriminate properties, and confirmed 
previous findings in social anxiety samples. The scale differentiated between active and 
passive social withdrawal. Lastly, self-esteem explained a significant amount of the variance 
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in social anxiety, even after controlling for delusions, suspiciousness and depression in the 
final model. 
Conclusion: The study shows that the LSAS-SR can be used to assess social anxiety in first 
episode psychosis as it revealed satisfactory psychometric properties. Furthermore, it 
demonstrated that it was able to differentiate between active and passive social withdrawal 
and finally that self-esteem is a contributing factor to social anxiety. The results support the 
use of this measure in assessment of social anxiety in both clinical settings and in research. 
Paper IV: Severe social anxiety in early psychosis: associated with poor premorbid 
functioning, depression and reduced quality of life. 
Objective: The relationship between anxiety and other clinical characteristics and 
functioning is not yet fully understood. The main aims of the present study were to test 
whether first episode psychosis patients with severe social anxiety shows poorer premorbid 
functioning, higher level of current clinical symptoms, better insight, lower current 
functioning and reduced quality of life.  
Method: A sample of 144 individuals was divided into three groups depending on current 
level of social anxiety symptoms measured by LSAS-SR; 1) no social anxiety (no-SaD), 2) 
clinically relevant symptoms of social anxiety (SaD) and 3)  generalized social anxiety 
symptoms (G- SaD). Analysis of variance was performed including measures of demographic 
and clinical characteristics. Furthermore, a hierarchical regression analysis was performed to 
explore possible predictors of quality of life.  
Results: Seventy-nine per cent of the sample had some clinical symptoms of social anxiety, 
and 68 (47%) met the criteria for G-SaD. There were no significant differences between the 
three groups for age, education or primary diagnosis. Being in the G-SaD group was 
associated with poorer premorbid adjustment, lower social functioning, lower self-esteem 
and higher levels of depression, while there were no group differences in level of psychotic 
symptoms. Furthermore, the G-SaD group revealed a higher awareness of illness more 
related to depression and low self-esteem, than to psychotic symptoms, and experienced 
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reduced quality of life. In the final hierarchic regression model we found that higher level of 
social anxiety predicted poorer quality of life even when adjusted for psychotic symptoms 
and depression. 
Conclusion: The current study indicates that those mostly impaired by social anxiety, exhibit 
distinct clinical patterns and are more impaired on several measures as; poorer premorbid 
functioning, higher levels of depression and lower self-esteem, despite the fact that there 
were no significant differences between the groups on measures of psychotic symptoms. 
Furthermore, social anxiety is an important factor associated with poorer quality of life, an 
outcome measure of utmost importance 
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5. DISCUSSION 
5.1. Discussion of main results  
The current thesis has focused on emotional dysfunction in first episode psychotic disorders. 
It has explored relevant associations regarding possible pathways to emotional dysfunction 
as previously described. Pertaining the developmental pathway, paper I, II and IV are all 
concerned with the relationship between premorbid functioning and symptoms of 
emotional dysfunction in terms of depression (paper I), self-esteem (paper II) and social 
anxiety (paper IV). All papers (paper I-IV) discuss issues related to the second pathway, 
viewing emotional dysfunction as intrinsic to the psychotic episode, but only paper II 
specifically analyzes the role of emotional dysfunction in the formation of psychotic 
symptoms. In paper IV the third pathway is explored in relation to how insight into illness 
and subjective quality of life are related to emotional dysfunction.   
The main findings of this thesis could be summarized as follows: 
1) Depression, social anxiety and low self-esteem are prevalent in first episode 
psychotic disorder. Gender specific factors were associated with the development of 
depression in psychosis. 
2) Depression, social anxiety and self-esteem are all significantly associated with poor 
premorbid adjustment.  
3) Self-esteem was associated with both hallucinations and persecutory delusions.  
4) The Liebowitz social anxiety scale as a self rated version revealed satisfactory 
psychometric properties and was able to differentiate between active and passive 
withdrawal. 
5)  The patients mostly impaired by symptoms of social anxiety were found to reveal 
poorer premorbid functioning, higher levels of depression and lower self-esteem 
than patients with mild or no symptoms of social anxiety despite no significant 
differences between the groups on measures of psychotic symptoms.  
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6) Social anxiety is an important predictor of quality of life. 
5.1.1. Prevalence of emotional dysfunction  
Overall, the findings presented support that depression, social anxiety and low self-esteem 
are prevalent in first episode psychosis. Close to 50 % of the patients had a lifetime history of 
one or more MDE, while 21 % met the criteria for a MDE at time of inclusion (paper I). 
Likewise, nearly half of the patients with a first episode psychosis experienced severe social 
anxiety problems when engaging in social interaction and performance (paper IV), and this 
group had significantly lower levels of self-esteem and more depression than those with no 
or minor problems with social anxiety.  
There exists a substantial body of literature demonstrating the importance of emotional 
dysfunction in chronic samples.  However, the findings in the current thesis indicate that 
symptoms of emotional dysfunction are prevalent from early on and that features of 
emotional dysfunction are associated with each other. After we finished the preparation of 
our four papers, two new publications supporting our findings were published. One study 
showed that from the prodromal phase and until one year after onset of psychosis 80 % FEP 
patients had experienced at least moderate levels of depression (Upthegrove et al., 2010).  
The other study found moderately low self-esteem among 167 FEP patients, and that self-
esteem predicted functional out-come at six months (Vracotas et al., 2010).  
5.1.2. Gender differences 
Results presented in paper I revealed that females were three times more likely than males 
to have experienced a MDE before onset of the first psychotic episode. Additionally, we 
found that the PANSS excitative symptoms explained a significant amount of the variance in 
current severity of depressive symptoms for women, while drinking habits were associated 
with depression in men in the final regression model. Lastly, findings presented in paper II 
demonstrated that women with FEP had lower levels of self-esteem than men. These 
findings are important as gender differences in schizophrenia have received minimal 
attention over the last years, despite the fact that women with schizophrenia differ from 
men in several aspects besides being more depressed. Women, diagnosed with a psychotic 
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disorder, are characterized by symptoms of more irritability, hostility, inappropriate affect 
and impulsivity compared to men with a psychotic disorder (Leung and Chue, 2000). 
The fact that women are more depressed than men mirrors the general population.  
Furthermore, substantial literature from studies in the general population indicates that 
women have significantly lower levels of self-esteem than men, even after correcting for 
level of depression (Accortt et al., 2008). Relevant explanations for these differences include 
the effect of genetic influence, neurotransmitter systems , brain asymmetry, hormones and 
stressful life events (Accortt et al., 2008).   
Perhaps our findings of more excitative symptoms and depression among women with FEP 
are an expression of dysfunctional coping strategies due to previous adverse life events, such 
as trauma. Stressful life events are of significant importance when discussing psychotic 
disorder in general. Traumatisation, abuse and neglect have for a long time been linked to 
the development of impulsive and affective personality traits in the general population (Ball 
and Links, 2009;Alexander et al., 2007), and the same factors have been associated with 
subsequent development of psychosis (Read et al., 2001). A review by Goodman and 
coworkers states that among women with severe mental illness the prevalence rates of 
physical and sexual abuse range from 51-97% (Goodman et al., 1997). A previous review 
found a weighted average of child sexual and physical abuse in women to be 69%, compared 
to 60% in men exploring samples of psychiatric in-patients (Read, 2004). A considerably 
larger number of females compared to males had been victims of sexual abuse and incest 
(50% and 29% vs. 28% and 7%).  
 Our findings of lowered self-esteem in women could be a reflection of more previous 
negative life events in this group. However, another possibility is that men with 
schizophrenia, due to cognitive disabilities and an earlier onset of psychosis than women are 
less able to express their feeling of inferiority and low self-esteem, and consequently rates 
themselves as having a higher level of self-esteem.  Also cultural tradition facilitates gender 
specific expectation which have an important influence both on behaviour and expression of 
pathology. 
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As for the male patients, the finding of a significant association between drinking habits in 
men and current severity of depressive symptoms supports previous studies (Verdoux et al., 
1999) and could imply a more focused assessment and subsequently more active treatment 
approach to problem drinking. However, this finding should be interpreted with care 
regarding gender and clinical implications, as there are reasons to assume that alcohol abuse 
in women is also associated with depression, but the prevalence of alcohol abuse among 
women with psychosis is lower.  A Swedish study found that male patients started to abuse 
alcohol at an earlier age than women (20.4 versus 28.0 years) (Cantor-Graae et al., 2001). 
This may explain the finding of gender differences concerning drinking habits obtained in the 
present thesis as this is both a FEP-study and has a skewed distribution with regard to 
gender. 
5.1.3. Emotional dysfunction and the developmental pathway 
We found that level of depression at start of treatment was significantly associated with 
poorer premorbid childhood social- and academic functioning (paper I). Furthermore, we 
found associations between premorbid adjustment and level of global self-esteem (paper II) 
and between premorbid adjustment and severe social anxiety (paper IV). We interpret our 
findings to be in line with the idea of a possibly disturbed developmental pathway to 
emotional dysfunction where premorbid adjustment mirrors developmental difficulties 
(Birchwood, 2003).  
There are studies which suggest that patients with psychotic disorders inherit a premorbid 
vulnerability that might reduce their ability to achieve and maintain social competence with 
a subsequent effect on premorbid adjustment (Bentall et al., 2001;Freeman et al., 
2002;Garety et al., 2001). A theoretical consequence of this vulnerability is the stress-
diathesis model which propose that patients with a severe psychotic disorder are more 
sensitive to stress  (Norman and Malla, 1993). This model views the vulnerability as mainly 
being of genetic or possible perinatal origin. However, premorbid adjustment might mirror a 
confluence of organic and psychosocial precipitating factors involved in the development of 
both emotional dysfunction and psychosis as described in a recent paper discussing 
environmental factors (van Os et al., 2010). It is tempting to discuss these psychological, 
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social and biological factors separately, but as they are intertwined, a more complex model 
including all three aspects has to be applied to comprehend the full picture. 
A Swedish cohort-study found that psychological constructs of difficulties in achieving and 
maintaining close relationships were the variables that were most significantly associated 
with later development of schizophrenia (Malmberg et al., 1998). In line with this is a study 
suggesting a link between shyness, schizophrenia and social dysfunction from early 
childhood (Goldberg and Schmidt, 2001).  
The results of the present thesis regarding premorbid adjustment are also of interest when 
discussing social and cognitive models expressed by social ranking theory (Gilbert and Allan, 
1998).  Studies of persons with auditory hallucinations have shown that voice hearers 
experience  a subordinate relationship  to their voices mirroring other social relationships 
and suggesting the existence of maladaptive  interpersonal schemata serving both 
(Birchwood et al., 2000b). These schemata are not necessarily a result of the psychotic 
illness, but a result of premorbid poor social adjustment and might be seen in line with 
theories of how long term experience of social defeat, can be a risk factor for psychosis 
(Selten and Cantor-Graae, 2005). All studies demonstrate how psychological mechanisms are 
in play, but there are several other explanatory factors involved to be able to explain this. 
Biological and social factors are implicated. Previous studies have shown that general 
cognitive abilities, exposure to bullying, social marginalization and abuse/neglect are the 
strongest predictors of social adjustment in psychosis (Selten and Cantor-Graae, 2005;Gracie 
et al., 2007;Garety et al., 2007). Furthermore, there are studies demonstrating that early 
traumatic events can result in persistence of fear-related neurophysiological patterns 
affecting emotional, behavioral, cognitive, and social functioning (Heim et al., 2000;Perry 
and Pollard, 1998;Read et al., 2001). Others have found a link between reduced flexibility in 
abstract thought, flexibly shifting mind set and social anxiety (Lysaker and Hammersley, 
2006;Lysaker et al., 2004) both in people with and without a severe mental disorder (Easter 
et al., 2005;Hariri et al., 2003). Hence, factors involved in cognition with presumable 
neurodevelopmetal correlates may be involved on several stages of the process. 
Furthermore, there are studies supporting the idea that childhood trauma and adverse life 
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events may act directly and mold the early brain development (Read et al., 2005;Bentall and 
Fernyhough, 2008).   
To sum up, there is a large body of evidence supporting multiple pathways to poor premobid 
function including i.e. psychosocial factors as shyness, difficulties achieving friends, feeling 
subordinate in relation to others, marginalisation, abuse, trauma and neglect. Furthermore 
biological factors as genetic vulnerability or acquired neurological disabilities causing 
cognitive dysfunction may interact and cause not only a predisposition to poor premorbid 
functioning, but to emotional dysfunction in psychosis as well. 
To explore this further, it might be necessary to look for subgroups. In paper IV we divided 
the group into three subgroups dependent upon level of social anxiety. Interestingly, the 
group mostly impaired by symptoms of social anxiety differed not only with regard to 
premorbid functioning, but on measures of self-esteem, depression and duration of 
untreated psychosis. As the group did not differ significantly on level of psychotic symptoms, 
this could imply that level of emotional dysfunction might be more related to aspects of 
premorbid functioning and indirectly reflects a higher load of precipitating pathoplastic 
factors which may be of psychosocial or biological origin.  
5.1.4. Emotional dysfunction as intrinsic to the psychotic episode 
In paper II we found self-esteem to be associated with both hallucinations and persecutory 
delusions in FEP. This is in line with previous studies (Bentall et al., 2008;Barrowclough et al., 
2003;Smith et al., 2006;Thewissen et al., 2008). Garety’s cognitive model of psychosis 
suggests that the experience of social adversity and lowered self-esteem eventually can lead 
to the development of psychotic symptoms (Garety et al., 2001). We would further argue 
that poor premorbid social adjustment with social withdrawal and subsequent 
marginalization will provide content to psychotic attribution by lack of correcting sources. 
This is supported by findings in studies of patients at high risk of developing psychosis 
(Cannon et al., 2008) and by findings in the general population, where negative ideas about 
oneself and others were found to predict paranoid thinking (Freeman et al., 2008b.  In a  
Dutch population sample, premorbid neuroticism and low self-esteem were found to be 
associated with subsequent development of psychosis or psychosis-like symptoms at 3-year 
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follow-up (Krabbendam et al., 2002). If we take the continuum hypothesis of psychosis into 
consideration (Van Os et al., 2009), it is not surprising to find the same pattern in a FEP 
sample, such as the present one, which is less influenced by a long history of psychosis. 
Depression has formerly been acknowledged to be the clearest example of an emotional 
disorder intrinsic to psychosis (Birchwood et al., 2000a). Nevertheless, the present study did 
not reveal any clear associations to positive psychotic symptoms in paper I. Nor did positive 
psychotic symptoms explain a significant part of the variance in depressive symptoms. 
However, our findings are in line with a more recent paper concluding that prodromal 
depression, not the severity of positive or negative symptoms, is predictive of depression in 
the early course (Upthegrove et al., 2010). Furthermore, the authors propose that there is a 
constant vulnerability to depression, which begins in adolescence, is manifest during the 
prodrome and can, depending on stressors, re-emerge at later time points. Considering the 
findings discussed previously, this repeats the question about whether at least aspects of 
emotional dysfunction in psychosis and psychosis per se, is the result of a common 
vulnerability of psychosocial and/or neurobiological origin.  
In paper IV, the study revealed no significant difference between the three groups divided by 
level of social anxiety, on current level of neither positive nor negative psychotic symptoms. 
Symptoms of social anxiety and level of psychosis seemed to be present together, but as 
more independent pathological entities. This was supported by the follow-up analysis in 
paper III which revealed that social anxiety was closely related to active social avoidance and 
not passive withdrawal which is a core component of the negative psychotic symptoms. 
Active avoidance was neither solely mediated through behaviour based on suspiciousness, 
delusions or depression, even though this will be the case for some individuals. Furthermore, 
findings described in paper III demonstrated that the LSAS-SR showed good psychometric 
properties in a sample of first episode psychosis patients and that the three factors indicated 
by the factor analysis to a large extent corresponded to factors identified in other 
populations (Baker et al., 2002;Safren et al., 1999). This indicates that both the 
phenomenology and the severity of social anxiety in psychosis most probably are 
indistinguishable from non-psychotic social anxiety disorder. That these findings are based 
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on self-reports suggest that patients have insight into their maladaptive thoughts and 
behaviour, indicating that they may also be amenable to change.  
To sum up, in the final regression model, only self-esteem was found to have a direct 
association and significantly predict level of psychotic symptoms (even though the 
contribution in itself was of modest size). It is noteworthy that both depression and social 
anxiety are associated with low self-esteem. This is exemplified by previous findings 
revealing that social anxiety in psychotic disorders is associated with shame and feeling 
inferior, and the notion that low self-esteem might underpin social anxiety in schizophrenia 
(Birchwood, 2003;Gumley et al., 2004a). However, it is possible that self-esteem acts as a 
key mediator of emotional dysfunction in general in psychotic disorders.  
5.1.5. Emotional dysfunction as a reaction to the psychotic episode 
Only paper IV verged on this last pathway to emotional dysfunction. We found that the 
group mostly impaired by social anxiety differed on several measures as depression and self-
esteem. This could be part of a psychological reaction to psychosis as described in the ‘social 
rank’ or ‘perceived stigma’ theory (Iqbal et al., 2000;Gilbert, 2001). Implicit in this theory is 
the assumption that an awareness of diagnosis and symptoms might have an impact on 
perceived stigma and social role. As a result the individual experiences reduced hope in 
future opportunities with regard to both social relationship and functioning with a 
subsequent fall in self-esteem, depression and anxiety. In our study, the patients with severe 
social anxiety reported a significantly higher level of ‘insight into illness’ compared to the 
other two groups, but interestingly, there were no significant differences between the 
groups concerning ‘insight into (psychotic) symptoms’ or ‘need for treatment’. A previous 
study of social anxiety with similar findings (positive association between social anxiety and 
insight into illness only) interpreted this as the patients’ awareness of their psychotic illness 
(Birchwood et al., 2006). However, the underlying items constituting this factor could be 
interpreted as questions concerning the patient’s general mental condition. The sub analysis 
in paper III testing this, failed to find any associations between psychotic symptoms and 
‘insight into illness’, on the contrary,  it confirmed a significant association between ‘insight 
into illness’ and  depression and social anxiety. Hence, we concluded that the patients 
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actually were rating their level of social discomfort and/or depression rather than insight 
into having a psychotic illness. Furthermore, there were no significant differences between 
the three groups concerning positive and negative symptoms, but the G-SaD group differed 
both in GAF-s and GAF-f. This might reflect higher depression/social anxiety scores and/or 
reduced functioning due to depression and/or social anxiety with active withdrawal.  
To sum up, emotional dysfunction might develop as a reaction to the psychotic episode, but 
there are indications in the present study, that emotional difficulties have a history dating 
backwards and possibly precede the first episode. This does not preclude the possibility that 
the episode per se, or the reaction to it, may further deteriorate the emotional dysfunction. 
Interesting in this regard is the finding of a continuously increasing DUP between the three 
social anxiety groups, even though the only significant difference was to be found between 
those with no social anxiety compared to the other two groups.  
5.2. Methodology 
5.2.1. Sample representativity and generalizability 
The Norwegian Health Care system is catchment area based and publicly funded. This should 
diminish the possibility of sample recruitment bias based upon geographic or socioeconomic 
differences. However, there are reasons to be concerned whether this is the case.  All 
patients described in paper I are recruited from the hospitals in Oslo county or the two 
nearby counties. The samples represented in paper II-IV included patients from Innlandet 
Hospital Trust with a catchment area representing mid-Norway, a more sparsely populated 
area. As displayed in Appendix 1, the duration of untreated psychosis is considerably longer 
in the late samples. Thus, it is possible that the patients recruited from Innlandet Hospital 
Trust has been ill for a longer period of time, and thereby could reduce the generalisablity of 
our results. However, there were only minor differences on the other demographic variables 
listed in Appendix 2. Furthermore, including patients from more sparsely populated areas 
will better reflect the source population and the distribution of patients in Norway. Overall, 
this might be a fairly good picture representing the general situation. 
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Norway does not have a public register where all diagnoses given at discharge from 
treatment are available. We were thus not able to gather data on subjects who either 
declined to participate or was not invited be their clinician. This made it impossible to 
accurately estimate the rate of participation. There are several reasons why this may have 
caused a selection bias. First, individuals not being able to make an informed consent were 
not asked to participate. We furthermore assume that individuals severely impaired by their 
psychotic symptoms, depression or cognitive deficits in many cases declined or was not 
asked to participate because their clinician found it unethical to expose them for several 
hours of assessment. On the other hand, it is possible that very well functioning patients 
with a first episode psychosis not wanting to identify with a socially stigmatised group, 
declined to participate. This would imply that we are generalising from a group representing 
the majority, but with a bias towards loss of information regarding patients with a very low 
or a very high level of functioning – as in all studies of patients with severe mental disorders. 
The patients were referred to the project via the professional who was responsible for the 
main treatment. This could be a physician, psychologist, nurse or specialised social worker. 
Professionals’ attitudes towards research vary considerably not only between departments, 
but also within departments, and probably between different professional groups. Different 
motives could lie behind a reluctance to refer patients as worry about the extra burden a 
thorough assessment would put on the patient. This would bias the sample towards better 
functioning patients. However, the opposite might be more relevant, that there was a 
tendency towards referral of those patients who constituted a problem with regard to 
diagnostic assessment because of a blurred or atypical history. This is based on the 
conviction that research has to give something back to the institution in form of diagnostic 
help. Ultimately, this would bias towards less of the more common pictures of the diagnostic 
subgroups. Others might have previously “disappointing” experiences with former patients 
who turned out to receive a different diagnosis after assessment in the project than was 
expected in the clinic, thereby imposing a suspicious feeling towards the project. 
To avoid the above mentioned biases, great effort was put on providing both written and 
verbal information about the project to professionals and patients. Furthermore, the 
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research fellows, that were responsible for including patients, regularly participated in 
meetings at the different units to locate individuals suitable for recruitment. When patients 
had been assessed, time was set off to go through the written report together with both 
patient and clinician to be able to provide answers to questions about the report or the 
diagnosis. This is the same procedure as in the former early intervention in psychosis study 
(TIPS-study) which recruited from one of the catchment areas in the presents study found 
incidence rates over a four year period of 12-17/ 100 000 (Melle et al., 2005). The TIPS-study   
is comparable to the TOP-study that has found almost similar rate of referrals of patients to 
the first-episode studies over a two year period, albeit in the lower range compared to TIPS; 
12-14/100 000 (Faerden, 2009), and resembles findings elsewhere in the literature (Goldner 
et al., 2002). Overall, we assume that satisfactory efforts were made to reduce the selection 
bias as much as possible, and thereby reduce threats to external validity (Shadish et al., 
2002).  
5.2.2. Validity and reliability of assessments 
The diagnostic and clinical assessment tools applied in the current study are all widely used 
instruments. To secure reliable assessments, the TOP-study has included in their program a 
standardised procedure including supervised training in all parts of the protocol and all 
research fellows responsible for inclusion participated in an extensive training program in 
diagnostic assessment led by Professor Joseph Ventura from the UCLA. Furthermore, tests 
for inter-rater reliability for SCID, PANSS and GAF were regularly conducted (for more 
detailed information about test results, see Methods). 
In addition to the clinician rated instruments, self-report instruments were employed to 
answer some of the research questions. There are several reasons why the use of self-report 
could be a potential bias in research on psychotic disorders as; denial, shame, cognitive 
difficulties or distrust as to how the project will administer the information gathered. These 
possible threats to the internal validity (Shadish et al., 2002) are not specific for self-report 
though, but could as well be in play when using clinician rated instruments. To minimize 
these, a considerable amount of time was spent to strengthen the alliance between the 
investigator and the patient to diminish distrust towards both the investigator and the 
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project. Psychoeducation was also applied both to inform, but also to initiate hope and 
reduce stigma. Furthermore, cultural and ethnic diversity might be of importance in self-
report as there is less opportunity to gather additional information if you worry whether the 
person actually understood you correctly. To minimize this possible source of bias, great 
effort was put into explaining each participant that the main investigator would answer all 
questions necessary to understand and complete the forms. Besides, all instruments 
contained written information about procedure and how to rate it.  
However, previous research on this issue has demonstrated that standardized self-
administered questionnaires on clinical outcome measures in schizophrenia show relatively 
good agreement with clinician ratings (Burlingame et al., 2005;Hamera et al., 1996). All self-
report instruments referred to in the present thesis are widely used in studies of psychotic 
disorders and have been extensively validated. Only the LSAS-SR had not been thoroughly 
validated in a psychosis sample. The findings in paper III documented that social anxiety 
reported via self-rating yielded both valid and reliable results and revealed dimensions 
comparable to what is found in a general sample of patients with social anxiety disorder. 
Hence, we conclude that even though we can not rule out the possibility of biases 
mentioned above, we find the preferred instruments to have satisfactory psychometric 
properties used as self-report in psychotic disorder and that threat to internal validity were 
properly handled. 
5.2.3. Strengths and weaknesses of the study 
There are some strengths and weaknesses in the present study that needs to be described. 
Importantly, the study was financially supported by public grants and was not confounded 
by economical interests. The naturalistic and catchment-area based design with a multi-site 
organisation combined with the effect of  a well function public Health Service has a strong 
impact on the generalizability of this project. Furthermore, the organization of the TOP-
study with its emphasis on reliability, regular supervision and organized training modules 
add to the reliability of the results.  
There are several limitations to the present study. The cross-sectional design makes it 
impossible to conclude regarding the direction of the associations between depression and 
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course of illness. There are, as usual in FEP studies, relatively more men compared to women 
in the present study. The distribution is though similar to what is found in other first episode 
psychosis studies. The retrospective diagnosis of earlier MDE’s and PAS might be 
confounded by the patients’ ability to remember the details correctly. However, as psychotic 
disorders are rare, a prospective study is difficult to perform, and hence, the advantage of 
being able to study these features in a FEP sample might be considered a reasonable 
solution. 
Studying self-esteem in this context is a difficult issue. There are still uncertainties about 
what kind of self-esteem that has the most pronounced impact on the individual’s quality of 
life and functioning. As previously mentioned, we have only measured global self-esteem, 
while it might be that the ability to measure several aspects of self-esteem including self-
esteem instability would have added more knowledge to this issue. There are limitations to 
how many measures and interventions you can add, as a single research fellow, to an 
extensive protocol when entering a large collaborative study as the TOP-study. The same 
problem is part of the studies in social anxiety. It would have been preferable to have a more 
extensive battery of instruments to measure social anxiety including clinician rated 
instruments to be able to compare. Furthermore, our findings of emotional dysfunction in 
first episode psychosis would have benefitted from a matched control group without 
psychotic disorder.  
 5.3. Clinical implications  
Both depression and social anxiety were significant predictors of subjective QoL. The present 
study thus supports previous research pointing to the importance of incorporating targeted 
monitoring and treatment of affective and anxiety symptomatology in severe mental illness 
(Hansson, 2006).  The importance of being aware of depression is obvious as it is prevalent 
in psychosis and acts as an important contributor to the increased risk of suicide (Melle et 
al., 2006;Barrett et al., 2010).  Furthermore, both social anxiety and depression are rarely a 
target of targeted therapeutic treatment and are often not recognized in the clinic due to 
focus on the traditional positive and negative symptoms (Cosoff and Hafner, 1998;Schneier 
et al., 1992). Considering evidence for new therapeutic gains as CBT has been proven 
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effective as adjunctive treatment for social anxiety in psychosis (Kingsep et al., 2003;Halperin 
et al., 2000), a more active approach towards recognition and treatment of social anxiety 
should be applied, and interventions aiming to reduce depression should be tested. 
Furthermore, a more focused living skills training to enhance social functioning targeted 
towards self-care, occupational, leisure and recreation, friendship and intimacy skills would 
be particularly relevant (Falloon et al., 1998).  In line with this, cognitive behavioural therapy 
aiming to improve self-esteem with focus on correcting misattributing tendencies has 
showed clinical benefits in terms of both increased self-esteem, reduced positive symptoms 
and improved social functioning (Hall and Tarrier, 2003). Validated instruments to capture 
these symptoms have to be applied and follow as a natural part of the assessments in 
psychotic disorders.  
Lastly, these implications are in line with recently published hopes for future treatment 
development; treatment addressing both underlying neurobiological vulnerability and 
aiming to protect against environmental risks (van Os and Kapur, 2009). 
5.4. Implications for future research 
Future research would benefit from a more thorough exploration of premorbid functioning 
to reveal what factors implicit in this term do have a significant impact on development of 
emotional dysfunction. There are several studies confirming how trauma and abuse do 
predict anxiety and depression, but more studies are needed to explore the relation 
between cognition and emotional functioning and between neglect and emotional 
functioning in psychosis. Hypothetically, this could lead to a more targeted approach to 
intervention and would be useful in treatment of individuals in risk of developing psychosis.  
Future research would benefit from a closer link between child and adult psychiatry to 
explore if developmental psychology could provide more information about the role of self-
esteem and its formation during childhood and early adulthood in persons at risk of 
developing a severe mental disorder such as a psychotic disorder. 
61 
 
Furthermore, studies to clarify whether level of emotional dysfunction in general actually 
divide these patients into clinically meaningful subgroups with different needs regarding 
treatment and rehabilitation would be of interest. 
Lastly, gender differences have been a neglected area of research within psychotic disorders 
during the last decade, even though we do know they exist. There are to our knowledge no 
studies on gender differences regarding social anxiety in psychosis, which would be of 
interest as one theory behind the fact that males tends to be more withdrawn than women 
has been linked to the later onset of psychosis in women. However, this might not be the 
only reason, another option is that men with psychosis do have more severe cognitive 
impairment related to social adjustment on the basis of developmental problems. This has 
not yet been explored. Furthermore, studies aiming to explore the effect of personality traits 
and gender with regard to symptoms, treatment and diagnosis, are warranted. 
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6. CONCLUSION 
Depression, social anxiety and lowered self-esteem are features frequently encountered in 
first episode psychosis. The current findings lend support to previous theories of multiple, 
but not mutually exclusive pathways to emotional dysfunction in psychosis. The strong 
relationship between the various comorbid conditions and premorbid adjustment found in 
the present material, indicate that for a large subgroup, these difficulties may have a history 
preceding the onset of psychosis. Furthermore, findings related to differences between 
groups depending on level of social anxiety could indicate that high levels of emotional 
dysfunction might reflect vulnerability for mental disorders in general as a result of a more 
developmental pathway. Subsequently, these individuals will be more prone to developing 
depression and anxiety in addition to psychosis.  
However, both depression and social anxiety exist as separate entities and are not clearly 
linked to positive psychotic symptoms, while self-esteem may significantly contribute to 
level of positive psychotic symptoms. Considering the strong associations between self-
esteem and depression and social anxiety respectively, self-esteem could be a key to future 
intervention. Interesting in this respect, is our use and validation of a self-report 
questionnaire emphasising that self-reported symptoms of social anxiety in a sample of first 
episode psychosis patients yields similar factors as in samples of non-psychotic patients. This 
adds strongly to moderation and application of validated treatment procedures for 
emotional dysfunction used in non-psychotic populations.   
Finally, the present results indicate that aspects of emotional dysfunction do have an impact 
on quality of life independent of psychotic symptoms. Thus, the current thesis supports a 
more active approach towards both recognition and treatment of emotional dysfunction in 
terms of depression, social anxiety and lowered self-esteem, as quality of life has to be 
considered an outcome measure of utmost importance.  
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7. APPENDIX  
Appendix 1: Abbreviations 
FEP First Episode Psychosis 
GAF-s Global Assessment of Functioning scale - symptom 
GAF-f Global Assessment of Functioning scale - function 
G-SaD General Social anxiety disorder 
ICD-10 Classification of Mental and Behavioural Disorders -10 
IQ Intelligence Quotient 
LSAS-SR Liebowitz Social Anxiety Scale - Self-rated version 
MDE Major Depressive Episode 
SCI-PANSS Structured Clinical Interview for the Positive And Negative Syndrome Scale 
PAS Premorbid Adjustment Scale 
RSES Rosenberg Self-Esteem Scale 
SaD Social anxiety Disorder 
SCID - I Structured Clinical Interview for DSM-IV Axis I Disorders 
SD Standard Deviation 
TOP study Thematically Organized Psychosis research study 
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APPENDIX 3: The five factor model of the Positive and Negative Syndrome Scale 
(PANSS) for Schizophrenia: 
 
Positive factor 
P1 Delusions 
P3 Hallucination 
P5 Grandiosity 
G9 Unusual thougt content 
G12 Lack of insight 
Negative factor 
N1 Blunted affect 
N2 Emotional withdrawal 
N3 Poor rapport 
N4 Apathetic social withdrawal 
N6 Lack of flow 
G5 Mannerism 
G7 Motor retardation 
G11 Poor attention 
G13 Disturbance of volition 
G16 Active social avoidance 
Excitative factor 
P4 Excitement 
P7 Hostility 
G4 Tension 
G8 Uncooperativeness 
G14 Poor impulse control 
Depressive factor 
G1 Somatic concern 
G2 Anxiety 
G3 Guilt feelings 
G6 Depression 
G15 Preoccupation 
Cognitive factor 
P2 Disorganized 
N5 Abstract thinking 
G10 Disorientation 
                   (Bentsen et al.  1996) 
66 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
67 
 
REFERENCES 
 
 
Reference List 
 
Accortt,E.E., Freeman,M.P. and Allen,J.J., 2008. Women and major depressive disorder: clinical 
perspectives on causal pathways. J Womens Health (Larchmt ). 17, 1583-1590. 
Achim,A.M., Maziade,M., Raymond,E., Olivier,D., Merette,C. and Roy,M.A., 2009. How Prevalent Are 
Anxiety Disorders in Schizophrenia? A Meta-Analysis and Critical Review on a Significant 
Association. Schizophr Bull. 
Addington,D., Addington,J. and Schissel,B., 1990. A depression rating scale for schizophrenics. 
Schizophr Res. 3, 247-251. 
Addington,D.D., Azorin,J.M., Falloon,I.R., Gerlach,J., Hirsch,S.R. and Siris,S.G., 2002. Clinical issues 
related to depression in schizophrenia: an international survey of psychiatrists. Acta 
Psychiatr Scand. 105, 189-195. 
Alexander,J.L., Dennerstein,L., Kotz,K. and Richardson,G., 2007. Women, anxiety and mood: a review 
of nomenclature, comorbidity and epidemiology. Expert Rev Neurother. 7, S45-S58. 
American Psychiatric Association, 1994. Diagnostic and statistical manual of mental disorders DSM 
IV. 4th ed. American Psychiatric Association, Washington DC. 
Baker,S.L., Heinrichs,N., Kim,H.J. and Hofmann,S.G., 2002. The liebowitz social anxiety scale as a self-
report instrument: a preliminary psychometric analysis. Behav Res Ther. 40, 701-715. 
Ball,J.S. and Links,P.S., 2009. Borderline personality disorder and childhood trauma: evidence for a 
causal relationship. Curr Psychiatry Rep. 11, 63-68. 
Bardenstein,K.K. and McGlashan,T.H., 1990. Gender differences in affective, schizoaffective, and 
schizophrenic disorders. A review. Schizophr Res. 3, 159-172. 
68 
 
Barrett,E.A., Sundet,K., Faerden,A., Agartz,I., Bratlien,U., Romm,K.L., Mork,E., Rossberg,J.I., 
Steen,N.E., Andreassen,O.A. and Melle,I., 2010. Suicidality in first episode psychosis is 
associated with insight and negative beliefs about psychosis. Schizophr Res. 
Barrowclough,C., Tarrier,N., Humphreys,L., Ward,J., Gregg,L. and Andrews,B., 2003. Self-esteem in 
schizophrenia: relationships between self-evaluation, family attitudes, and symptomatology. 
J Abnorm Psychol. 112, 92-99. 
Bartels,S.J. and Drake,R.E., 1988. Depressive symptoms in schizophrenia: comprehensive differential 
diagnosis. Compr Psychiatry. 29, 467-483. 
Beer,M.D., 1996. The dichotomies: psychosis/neurosis and functional/organic: a historical 
perspective. Hist Psychiatry. 7, 231-255. 
Bentall,R.P., Corcoran,R., Howard,R., Blackwood,N. and Kinderman,P., 2001. Persecutory delusions: a 
review and theoretical integration. Clin Psychol Rev. 21, 1143-1192. 
Bentall,R.P. and Fernyhough,C., 2008. Social predictors of psychotic experiences: specificity and 
psychological mechanisms. Schizophr Bull. 34, 1012-1020. 
Bentall,R.P., Rowse,G., Kinderman,P., Blackwood,N., Howard,R., Moore,R., Cummins,S. and 
Corcoran,R., 2008. Paranoid delusions in schizophrenia spectrum disorders and depression: 
the transdiagnostic role of expectations of negative events and negative self-esteem. J Nerv 
Ment Dis. 196, 375-383. 
Bentsen,H., Munkvold,O.G., Notland,T.H., Boye,B., Bjorge,H., Lersbryggen,A.B., Oskarsson,K.H., 
BergLarsen,R. and Malt,U.F., 1996. The interrater reliability of the Positive and Negative 
Syndrome Scale (PANSS). International Journal of Methods in Psychiatric Research. 6, 227-
235. 
Berman,A.H., Bergman,H., Palmstierna,T. and Schlyter,F., 2005. Evaluation of the Drug Use Disorders 
Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish 
population sample. Eur Addict Res. 11, 22-31. 
Bermanzohn,P.C., Porto,L., Arlow,P.B., Pollack,S., Stronger,R. and Siris,S.G., 2000. Hierarchical 
diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes. Schizophr Bull. 
26, 517-525. 
Birchwood,M., 2003. Pathways to emotional dysfunction in first-episode psychosis. Br J Psychiatry. 
182, 373-375. 
69 
 
Birchwood,M. and Chadwick,P., 1997. The omnipotence of voices: testing the validity of a cognitive 
model. Psychol Med. 27, 1345-1353. 
Birchwood,M., Iqbal,Z., Chadwick,P. and Trower,P., 2000a. Cognitive approach to depression and 
suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression. Br J Psychiatry. 177, 
516-521. 
Birchwood,M., Iqbal,Z. and Upthegrove,R., 2005. Psychological pathways to depression in 
schizophrenia: studies in acute psychosis, post psychotic depression and auditory 
hallucinations. Eur Arch Psychiatry Clin Neurosci. 255, 202-212. 
Birchwood,M., Mason,R., MacMillan,F. and Healy,J., 1993. Depression, demoralization and control 
over psychotic illness: a comparison of depressed and non-depressed patients with a chronic 
psychosis. Psychol Med. 23, 387-395. 
Birchwood,M., Meaden,A., Trower,P., Gilbert,P. and Plaistow,J., 2000b. The power and omnipotence 
of voices: subordination and entrapment by voices and significant others. Psychol Med. 30, 
337-344. 
Birchwood,M., Smith,J., Drury,V., Healy,J., Macmillan,F. and Slade,M., 1994. A self-report Insight 
Scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand. 89, 62-
67. 
Birchwood,M., Trower,P., Brunet,K., Gilbert,P., Iqbal,Z. and Jackson,C., 2006. Social anxiety and the 
shame of psychosis: A study in first episode psychosis. Behav Res Ther. 
Blairy,S., Linotte,S., Souery,D., Papadimitriou,G.N., Dikeos,D., Lerer,B., Kaneva,R., Milanova,V., 
Serretti,A., Macciardi,F. and Mendlewicz,J., 2004. Social adjustment and self-esteem of 
bipolar patients: a multicentric study. J Affect Disord. 79, 97-103. 
Blanchard,J.J., Mueser,K.T. and Bellack,A.S., 1998. Anhedonia, positive and negative affect, and social 
functioning in schizophrenia. Schizophr Bull. 24, 413-424. 
Bowins,B. and Shugar,G., 1998. Delusions and self-esteem. Can J Psychiatry. 43, 154-158. 
Braga,R.J., Petrides,G. and Figueira,I., 2004. Anxiety disorders in schizophrenia. Compr Psychiatry. 45, 
460-468. 
Buckley,P.F., Miller,B.J., Lehrer,D.S. and Castle,D.J., 2009. Psychiatric comorbidities and 
schizophrenia. Schizophr Bull. 35, 383-402. 
70 
 
Burlingame,G.M., Dunn,T.W., Chen,S., Lehman,A., Axman,R., Earnshaw,D. and Rees,F.M., 2005. 
Selection of outcome assessment instruments for inpatients with severe and persistent 
mental illness. Psychiatr Serv. 56, 444-451. 
Candido,C.L. and Romney,D.M., 1990. Attributional style in paranoid vs. depressed patients. Br J Med 
Psychol. 63 ( Pt 4), 355-363. 
Cannon,T.D., Cadenhead,K., Cornblatt,B., Woods,S.W., Addington,J., Walker,E., Seidman,L.J., 
Perkins,D., Tsuang,M., McGlashan,T. and Heinssen,R., 2008. Prediction of psychosis in youth 
at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 65, 
28-37. 
Cannon-Spoor,H.E., Potkin,S.G. and Wyatt,R.J., 1982. Measurement of premorbid adjustment in 
chronic schizophrenia. Schizophr Bull. 8, 470-484. 
Cantor-Graae,E., Nordstrom,L.G. and McNeil,T.F., 2001. Substance abuse in schizophrenia: a review 
of the literature and a study of correlates in Sweden. Schizophr Res. 48, 69-82. 
Cassano,G.B., Pini,S., Saettoni,M. and Dell'Osso,L., 1999. Multiple anxiety disorder comorbidity in 
patients with mood spectrum disorders with psychotic features. Am J Psychiatry. 156, 474-
476. 
Chadwick,P. and Birchwood,M., 1994. The omnipotence of voices. A cognitive approach to auditory 
hallucinations. Br J Psychiatry. 164, 190-201. 
Corrigan,P.W. and Watson,A.C., 2002. Understanding the impact of stigma on people with mental 
illness. World Psychiatry. 1, 16-20. 
Cosoff,S.J. and Hafner,R.J., 1998. The prevalence of comorbid anxiety in schizophrenia, 
schizoaffective disorder and bipolar disorder. Aust N Z J Psychiatry. 32, 67-72. 
Craddock,N., O'Donovan,M.C. and Owen,M.J., 2006. Genes for schizophrenia and bipolar disorder? 
Implications for psychiatric nosology. Schizophr Bull. 32, 9-16. 
Crocker,J. and Wolfe,C.T., 2001. Contingencies of self-worth. Psychol Rev. 108, 593-623. 
Drake,R.E., Gates,C., Whitaker,A. and Cotton,P.G., 1985. Suicide among schizophrenics: a review. 
Compr Psychiatry. 26, 90-100. 
71 
 
Easter,J., McClure,E.B., Monk,C.S., Dhanani,M., Hodgdon,H., Leibenluft,E., Charney,D.S., Pine,D.S. and 
Ernst,M., 2005. Emotion recognition deficits in pediatric anxiety disorders: implications for 
amygdala research. J Child Adolesc Psychopharmacol. 15, 563-570. 
Faerden,A. Apathy in First Episode Psychosis Patients.  2009.  Institute of Psychiatry, Faculty of 
Medicine, University of Oslo.  
               Thesis/Dissertation 
Falloon,I.R., Coverdale,J.H., Laidlaw,T.M., Merry,S., Kydd,R.R. and Morosini,P., 1998. Early 
intervention for schizophrenic disorders. Implementing optimal treatment strategies in 
routine clinical services. OTP Collaborative Group. Br J Psychiatry Suppl. 172, 33-38. 
Fannon,D., Hayward,P., Thompson,N., Green,N., Surguladze,S. and Wykes,T., 2009. The self or the 
voice? Relative contributions of self-esteem and voice appraisal in persistent auditory 
hallucinations. Schizophr Res. 112, 174-180. 
Fenton,W.S., 2000. Depression, suicide, and suicide prevention in schizophrenia. Suicide Life Threat 
Behav. 30, 34-49. 
First,M., Spitzer,R., Gibbon,M. and Williams,J.B.W., 1995. Structured Clinical Interview for DSM-IV 
Axis I Disorder: Patient Edition (SCID-P), Version 2. New York State Psychiatric Institute, 
Biometrics Research, New York, NY. 
Freeman,D. and Garety,P.A., 2003. Connecting neurosis and psychosis: the direct influence of 
emotion on delusions and hallucinations. Behav Res Ther. 41, 923-947. 
Freeman,D., Garety,P.A. and Kuipers,E., 2001. Persecutory delusions: developing the understanding 
of belief maintenance and emotional distress. Psychol Med. 31, 1293-1306. 
Freeman,D., Garety,P.A., Kuipers,E., Fowler,D. and Bebbington,P.E., 2002. A cognitive model of 
persecutory delusions. Br J Clin Psychol. 41, 331-347. 
Freeman,D., Gittins,M., Pugh,K., Antley,A., Slater,M. and Dunn,G., 2008. What makes one person 
paranoid and another person anxious? The differential prediction of social anxiety and 
persecutory ideation in an experimental situation. Psychol Med. 38, 1121-1132. 
Fresco,D.M., Coles,M.E., Heimberg,R.G., Liebowitz,M.R., Hami,S., Stein,M.B. and Goetz,D., 2001. The 
Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report 
and clinician-administered formats. Psychol Med. 31, 1025-1035. 
72 
 
Freud,S., 1924. The Essentials of Psycho-Analysis. Chapter 10: Neurosis and psychosis (1924). Vintage 
2005, London. 
Garety,P.A., Bebbington,P., Fowler,D., Freeman,D. and Kuipers,E., 2007. Implications for 
neurobiological research of cognitive models of psychosis: a theoretical paper. Psychol Med. 
37, 1377-1391. 
Garety,P.A., Freeman,D., Jolley,S., Dunn,G., Bebbington,P.E., Fowler,D.G., Kuipers,E. and Dudley,R., 
2005. Reasoning, emotions, and delusional conviction in psychosis. J Abnorm Psychol. 114, 
373-384. 
Garety,P.A., Kuipers,E., Fowler,D., Freeman,D. and Bebbington,P.E., 2001. A cognitive model of the 
positive symptoms of psychosis. Psychol Med. 31, 189-195. 
Gift,T.E., Strauss,J.S., Kokes,R.F., Harder,D.W. and Ritzler,B.A., 1980. Schizophrenia: affect and 
outcome. Am J Psychiatry. 137, 580-585. 
Gilbert,P., 2001. Evolution and social anxiety. The role of attraction, social competition, and social 
hierarchies. Psychiatr Clin North Am. 24, 723-751. 
Gilbert,P. and Allan,S., 1998. The role of defeat and entrapment (arrested flight) in depression: an 
exploration of an evolutionary view. Psychol Med. 28, 585-598. 
Goldberg,J.O. and Schmidt,L.A., 2001. Shyness, sociability, and social dysfunction in schizophrenia. 
Schizophr Res. 48, 343-349. 
Goldner,E.M., Hsu,L., Waraich,P. and Somers,J.M., 2002. Prevalence and incidence studies of 
schizophrenic disorders: a systematic review of the literature. Can J Psychiatry. 47, 833-843. 
Goodman,L.A., Rosenberg,S.D., Mueser,K.T. and Drake,R.E., 1997. Physical and sexual assault history 
in women with serious mental illness: prevalence, correlates, treatment, and future research 
directions. Schizophr Bull. 23, 685-696. 
Gracie,A., Freeman,D., Green,S., Garety,P.A., Kuipers,E., Hardy,A., Ray,K., Dunn,G., Bebbington,P. and 
Fowler,D., 2007. The association between traumatic experience, paranoia and hallucinations: 
a test of the predictions of psychological models. Acta Psychiatr Scand. 116, 280-289. 
Green,C., Garety,P.A., Freeman,D., Fowler,D., Bebbington,P., Dunn,G. and Kuipers,E., 2006. Content 
and affect in persecutory delusions. Br J Clin Psychol. 45, 561-577. 
73 
 
Green,M.F., 1996. What are the functional consequences of neurocognitive deficits in schizophrenia? 
Am J Psychiatry. 153, 321-330. 
Greenberg,J., Solomon,S., Pyszczynski,T., Rosenblatt,A., Burling,J., Lyon,D., Simon,L. and Pinel,E., 
1992. Why do people need self-esteem? Converging evidence that self-esteem serves an 
anxiety-buffering function. J Pers Soc Psychol. 63, 913-922. 
Greenfield,S.F., Strakowski,S.M., Tohen,M., Batson,S.C. and Kolbrener,M.L., 1994. Childhood abuse in 
first-episode psychosis. Br J Psychiatry. 164, 831-834. 
Gumley,A., O'Grady,M., Power,K. and Schwannauer,M., 2004a. Negative beliefs about self and 
illness: a comparison of individuals with psychosis with or without comorbid social anxiety 
disorder. Aust N Z J Psychiatry. 38, 960-964. 
Gumley,A., O'Grady,M., Power,K. and Schwannauer,M., 2004b. Negative beliefs about self and 
illness: a comparison of individuals with psychosis with or without comorbid social anxiety 
disorder. Aust N Z J Psychiatry. 38, 960-964. 
Gureje,O., Harvey,C. and Herrman,H., 2004. Self-esteem in patients who have recovered from 
psychosis: profile and relationship to quality of life. Aust N Z J Psychiatry. 38, 334-338. 
Haahr,U., Friis,S., Larsen,T.K., Melle,I., Johannessen,J.O., Opjordsmoen,S., Simonsen,E., Rund,B.R., 
Vaglum,P. and McGlashan,T., 2008. First-episode psychosis: diagnostic stability over one and 
two years. Psychopathology. 41, 322-329. 
Hafner,H., Loffler,W., Maurer,K., Hambrecht,M. and an der,H.W., 1999. Depression, negative 
symptoms, social stagnation and social decline in the early course of schizophrenia. Acta 
Psychiatr Scand. 100, 105-118. 
Hafner,H., Maurer,K., Trendler,G., an der,H.W., Schmidt,M. and Konnecke,R., 2005. Schizophrenia 
and depression: challenging the paradigm of two separate diseases--a controlled study of 
schizophrenia, depression and healthy controls. Schizophr Res. 77, 11-24. 
Halbreich,U. and Kahn,L.S., 2007. Atypical depression, somatic depression and anxious depression in 
women: are they gender-preferred phenotypes? J Affect Disord. 102, 245-258. 
Hall,P.L. and Tarrier,N., 2003. The cognitive-behavioural treatment of low self-esteem in psychotic 
patients: a pilot study. Behav Res Ther. 41, 317-332. 
Halperin,S., Nathan,P., Drummond,P. and Castle,D., 2000. A cognitive-behavioural, group-based 
intervention for social anxiety in schizophrenia. Aust N Z J Psychiatry. 34, 809-813. 
74 
 
Hamera,E.K., Schneider,J.K., Potocky,M. and Casebeer,M.A., 1996. Validity of self-administered 
symptom scales in clients with schizophrenia and schizoaffective disorders. Schizophr Res. 
19, 213-219. 
Hanssen,M., Bak,M., Bijl,R., Vollebergh,W. and van,O.J., 2005. The incidence and outcome of 
subclinical psychotic experiences in the general population. Br J Clin Psychol. 44, 181-191. 
Hansson,L., 2006. Determinants of quality of life in people with severe mental illness. Acta Psychiatr 
Scand Suppl. 46-50. 
Hariri,A.R., Mattay,V.S., Tessitore,A., Fera,F. and Weinberger,D.R., 2003. Neocortical modulation of 
the amygdala response to fearful stimuli. Biol Psychiatry. 53, 494-501. 
Harrison,G., Hopper,K., Craig,T., Laska,E., Siegel,C., Wanderling,J., Dube,K.C., Ganev,K., Giel,R., an 
der,H.W., Holmberg,S.K., Janca,A., Lee,P.W., Leon,C.A., Malhotra,S., Marsella,A.J., Nakane,Y., 
Sartorius,N., Shen,Y., Skoda,C., Thara,R., Tsirkin,S.J., Varma,V.K., Walsh,D. and Wiersma,D., 
2001. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J 
Psychiatry. 178, 506-517. 
Harrow,M., Yonan,C.A., Sands,J.R. and Marengo,J., 1994. Depression in schizophrenia: are 
neuroleptics, akinesia, or anhedonia involved? Schizophr Bull. 20, 327-338. 
Heim,C., Newport,D.J., Heit,S., Graham,Y.P., Wilcox,M., Bonsall,R., Miller,A.H. and Nemeroff,C.B., 
2000. Pituitary-adrenal and autonomic responses to stress in women after sexual and 
physical abuse in childhood. JAMA. 284, 592-597. 
Herz,M.I. and Lamberti,J.S., 1995. Prodromal symptoms and relapse prevention in schizophrenia. 
Schizophr Bull. 21, 541-551. 
Hirsch,S.R. and Jolley,A.G., 1989. The dysphoric syndrome in schizophrenia and its implications for 
relapse. Br J Psychiatry Suppl. 46-50. 
Hodgekins,J. and Fowler,D., 2010. CBT and recovery from psychosis in the ISREP trial: mediating 
effects of hope and positive beliefs on activity. Psychiatr Serv. 61, 321-324. 
Iqbal,Z., Birchwood,M., Chadwick,P. and Trower,P., 2000. Cognitive approach to depression and 
suicidal thinking in psychosis. 2. Testing the validity of a social ranking model. Br J Psychiatry. 
177, 522-528. 
Jaspers,K., 1963. General Psychopatology, trans. J. Hoening & M. Hamilton, Manchester: Manchester 
University Press pp. 577-578. 
75 
 
Johannessen,J.O., 2002. [Schizophrenia--incidence and significance]. Tidsskr Nor Laegeforen. 122, 
2011-2014. 
Johnstone,E.C., Ebmeier,K.P., Miller,P., Owens,D.G. and Lawrie,S.M., 2005. Predicting schizophrenia: 
findings from the Edinburgh High-Risk Study. Br J Psychiatry. 186, 18-25. 
Jones,S.H., Thornicroft,G., Coffey,M. and Dunn,G., 1995. A brief mental health outcome scale-
reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry. 166, 
654-659. 
Karatzias,T., Gumley,A., Power,K. and O'Grady,M., 2007. Illness appraisals and self-esteem as 
correlates of anxiety and affective comorbid disorders in schizophrenia. Compr Psychiatry. 
48, 371-375. 
Kay,S.R., Fiszbein,A. and Opler,L.A., 1987. The positive and negative syndrome scale (PANSS) for 
schizophrenia. Schizophr Bull. 13, 261-276. 
Kendler,K.S., Zachar,P. and Craver,C., 2010. What kinds of things are psychiatric disorders? Psychol 
Med. 1-8. 
Kernis,M.H., 2005. Measuring self-esteem in context: the importance of stability of self-esteem in 
psychological functioning. J Pers. 73, 1569-1605. 
Kessler,R.C., Stang,P., Wittchen,H.U., Stein,M. and Walters,E.E., 1999. Lifetime co-morbidities 
between social phobia and mood disorders in the US National Comorbidity Survey. Psychol 
Med. 29, 555-567. 
Kingsep,P., Nathan,P. and Castle,D., 2003. Cognitive behavioural group treatment for social anxiety in 
schizophrenia. Schizophr Res. 63, 121-129. 
Knights,A. and Hirsch,S.R., 1981. "Revealed" Depression and drug treatment for schizophrenia. Arch 
Gen Psychiatry. 38, 806-811. 
Koreen,A.R., Siris,S.G., Chakos,M., Alvir,J., Mayerhoff,D. and Lieberman,J., 1993. Depression in first-
episode schizophrenia. Am J Psychiatry. 150, 1643-1648. 
Koster,A., Lajer,M., Lindhardt,A. and Rosenbaum,B., 2008. Gender differences in first episode 
psychosis. Soc Psychiatry Psychiatr Epidemiol. 43, 940-946. 
76 
 
Krabbendam,L., Janssen,I., Bak,M., Bijl,R.V., de,G.R. and van,O.J., 2002. Neuroticism and low self-
esteem as risk factors for psychosis. Soc Psychiatry Psychiatr Epidemiol. 37, 1-6. 
Kuipers,E., Garety,P., Fowler,D., Freeman,D., Dunn,G. and Bebbington,P., 2006. Cognitive, emotional, 
and social processes in psychosis: refining cognitive behavioral therapy for persistent positive 
symptoms. Schizophr Bull. 32 Suppl 1, S24-S31. 
Larsen,T.K., Johannessen,J.O. and Opjordsmoen,S., 1998. First-episode schizophrenia with long 
duration of untreated psychosis. Pathways to care. Br J Psychiatry Suppl. 172, 45-52. 
Leung,A. and Chue,P., 2000. Sex differences in schizophrenia, a review of the literature. Acta 
Psychiatr Scand Suppl. 401, 3-38. 
Lichtenstein,P., Yip,B.H., Bjork,C., Pawitan,Y., Cannon,T.D., Sullivan,P.F. and Hultman,C.M., 2009. 
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a 
population-based study. Lancet. 373, 234-239. 
Lincoln,T.M., Peter,N., Schafer,M. and Moritz,S., 2009. Impact of stress on paranoia: an experimental 
investigation of moderators and mediators. Psychol Med. 39, 1129-1139. 
Link,B.G., Struening,E.L., Neese-Todd,S., Asmussen,S. and Phelan,J.C., 2001. Stigma as a barrier to 
recovery: The consequences of stigma for the self-esteem of people with mental illnesses. 
Psychiatr Serv. 52, 1621-1626. 
Linscott,R.J., Allardyce,J. and van,O.J., 2010. Seeking verisimilitude in a class: a systematic review of 
evidence that the criterial clinical symptoms of schizophrenia are taxonic. Schizophr Bull. 36, 
811-829. 
Lyon,H.M., Kaney,S. and Bentall,R.P., 1994. The defensive function of persecutory delusions. 
Evidence from attribution tasks. Br J Psychiatry. 164, 637-646. 
Lysaker,P.H., Bryson,G.J., Marks,K., Greig,T.C. and Bell,M.D., 2004. Coping style in schizophrenia: 
associations with neurocognitive deficits and personality. Schizophr Bull. 30, 113-121. 
Lysaker,P.H. and Hammersley,J., 2006. Association of delusions and lack of cognitive flexibility with 
social anxiety in schizophrenia spectrum disorders. Schizophr Res. 86, 147-153. 
Malmberg,A., Lewis,G., David,A. and Allebeck,P., 1998. Premorbid adjustment and personality in 
people with schizophrenia. Br J Psychiatry. 172, 308-313. 
77 
 
Marshall,M. and Rathbone,J., 2006. Early intervention for psychosis. Cochrane Database Syst Rev. 
CD004718. 
Martin,J.A. and Penn,D.L., 2001. Social cognition and subclinical paranoid ideation. Br J Clin Psychol. 
40, 261-265. 
McFarland,C. and Ross,M., 1982. Impact of causal attributions on affective reactions to success and 
failure. Journal of Personality and Social Psychology. 43, 937-946. 
McGlashan,T.H. and Carpenter,W.T., Jr., 1976. Postpsychotic depression in schizophrenia. Arch Gen 
Psychiatry. 33, 231-239. 
McGrath,J., Saha,S., Chant,D. and Welham,J., 2008. Schizophrenia: a concise overview of incidence, 
prevalence, and mortality. Epidemiol Rev. 30, 67-76. 
Melle,I., Haahr,U., Friis,S., Hustoft,K., Johannessen,J.O., Larsen,T.K., Opjordsmoen,S., Rund,B.R., 
Simonsen,E., Vaglum,P. and McGlashan,T., 2005. Reducing the duration of untreated first-
episode psychosis -- effects on baseline social functioning and quality of life. Acta Psychiatr 
Scand. 112, 469-473. 
Melle,I., Johannesen,J.O., Friis,S., Haahr,U., Joa,I., Larsen,T.K., Opjordsmoen,S., Rund,B.R., 
Simonsen,E., Vaglum,P. and McGlashan,T., 2006. Early detection of the first episode of 
schizophrenia and suicidal behavior. Am J Psychiatry. 163, 800-804. 
Melle,I., Larsen,T.K., Haahr,U., Friis,S., Johannesen,J.O., Opjordsmoen,S., Rund,B.R., Simonsen,E., 
Vaglum,P. and McGlashan,T., 2008. Prevention of negative symptom psychopathologies in 
first-episode schizophrenia: two-year effects of reducing the duration of untreated psychosis. 
Arch Gen Psychiatry. 65, 634-640. 
Michail,M. and Birchwood,M., 2009. Social anxiety disorder in first-episode psychosis: incidence, 
phenomenology and relationship with paranoia. Br J Psychiatry. 195, 234-241. 
Norman,R.M. and Malla,A.K., 1993. Stressful life events and schizophrenia. I: A review of the 
research. Br J Psychiatry. 162, 161-166. 
Owens,D.G., Miller,P., Lawrie,S.M. and Johnstone,E.C., 2005. Pathogenesis of schizophrenia: a 
psychopathological perspective. Br J Psychiatry. 186, 386-393. 
Pallanti,S., Quercioli,L. and Hollander,E., 2004. Social anxiety in outpatients with schizophrenia: a 
relevant cause of disability. Am J Psychiatry. 161, 53-58. 
78 
 
Palmer,B.A., Pankratz,V.S. and Bostwick,J.M., 2005. The lifetime risk of suicide in schizophrenia: a 
reexamination. Arch Gen Psychiatry. 62, 247-253. 
Pedersen,G., Hagtvet,K.A. and Karterud,S., 2007. Generalizability studies of the Global Assessment of 
Functioning-Split version. Compr Psychiatry. 48, 88-94. 
Perry,B.D. and Pollard,R., 1998. Homeostasis, stress, trauma, and adaptation. A neurodevelopmental 
view of childhood trauma. Child Adolesc Psychiatr Clin N Am. 7, 33-51, viii. 
Pilkonis,P.A., Feldman,H., Himmelhoch,J. and Cornes,C., 1980. Social anxiety and psychiatric 
diagnosis. J Nerv Ment Dis. 168, 13-18. 
Read,J., 2004. Models of Madness. Taylor & Francis Ltd. Routledge, East Sussex.. 
Read,J., Perry,B.D., Moskowitz,A. and Connolly,J., 2001. The contribution of early traumatic events to 
schizophrenia in some patients: a traumagenic neurodevelopmental model. Psychiatry. 64, 
319-345. 
Read,J., van,O.J., Morrison,A.P. and Ross,C.A., 2005. Childhood trauma, psychosis and schizophrenia: 
a literature review with theoretical and clinical implications. Acta Psychiatr Scand. 112, 330-
350. 
Rosenberg,M., 1965. Society and the adolescent self-image. Princeton University Press, Princeton, NJ. 
Rosenberg,M., 1986. The development of the self. Self-consept from middle childhood through 
adolescence. Hillsdale, NJ: Erlbaum. 
Rosenberg,M., 1989. Society and the adolescent self-image Wesleyan University Press, Connecticut. 
Roth,M., 1963. Neurosis, psychosis and the concept of disease in psychiatry. Acta Psychiatr Scand. 
39, 128-145. 
Safren,S.A., Heimberg,R.G., Horner,K.J., Juster,H.R., Schneier,F.R. and Liebowitz,M.R., 1999. Factor 
structure of social fears: The Liebowitz Social Anxiety Scale. J Anxiety Disord. 13, 253-270. 
Saunders,J.B., Aasland,O.G., Babor,T.F., de,l.F., Jr. and Grant,M., 1993. Development of the Alcohol 
Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of 
Persons with Harmful Alcohol Consumption--II. Addiction. 88, 791-804. 
79 
 
Schneier,F.R., Johnson,J., Hornig,C.D., Liebowitz,M.R. and Weissman,M.M., 1992. Social phobia. 
Comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry. 49, 282-288. 
Selten,J.P. and Cantor-Graae,E., 2005. Social defeat: risk factor for schizophrenia? Br J Psychiatry. 
187, 101-102. 
Shadish,W.R., Cook,T.D. and Campbell,D.T., 2002. Experimental and Quasi-Experimental Designs. 
Wadsworth, Belmont, USA. 
Silverstone,P.H., 1991. Low self-esteem in different psychiatric conditions. Br J Clin Psychol. 30 ( Pt 2), 
185-188. 
Silverstone,P.H. and Salsali,M., 2003. Low self-esteem and psychiatric patients: Part I - The 
relationship between low self-esteem and psychiatric diagnosis. Ann Gen Hosp Psychiatry. 2, 
2. 
Sim,K., Mahendran,R., Siris,S.G., Heckers,S. and Chong,S.A., 2004. Subjective quality of life in first 
episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Res. 129, 
141-147. 
Simonsen,C., Sundet,K., Vaskinn,A., Birkenaes,A.B., Engh,J.A., Faerden,A., Jonsdottir,H., Ringen,P.A., 
Opjordsmoen,S., Melle,I., Friis,S. and Andreassen,O.A., 2009. Neurocognitive Dysfunction in 
Bipolar and Schizophrenia Spectrum Disorders Depends on History of Psychosis Rather Than 
Diagnostic Group. Schizophr Bull. 
Siris,S.G., 1991. Diagnosis of secondary depression in schizophrenia: implications for DSM-IV. 
Schizophr Bull. 17, 75-98. 
Siris,S.G., 2000. Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic 
agents. Am J Psychiatry. 157, 1379-1389. 
Smith,B., Fowler,D.G., Freeman,D., Bebbington,P., Bashforth,H., Garety,P., Dunn,G. and Kuipers,E., 
2006. Emotion and psychosis: links between depression, self-esteem, negative schematic 
beliefs and delusions and hallucinations. Schizophr Res. 86, 181-188. 
Startup,H., Freeman,D. and Garety,P.A., 2007. Persecutory delusions and catastrophic worry in 
psychosis: developing the understanding of delusion distress and persistence. Behav Res 
Ther. 45, 523-537. 
Stein,M.B. and Chavira,D.A., 1998. Subtypes of social phobia and comorbidity with depression and 
other anxiety disorders. J Affect Disord. 50 Suppl 1, S11-S16. 
80 
 
Stein,M.B., Tancer,M.E., Gelernter,C.S., Vittone,B.J. and Uhde,T.W., 1990. Major depression in 
patients with social phobia. Am J Psychiatry. 147, 637-639. 
Surtees,P.G. and Kendell,R.E., 1979. The hierarchy model of psychiatric symptomatology: an 
investigation based on present state examination ratings. Br J Psychiatry. 135, 438-443. 
Thewissen,V., Bentall,R.P., Lecomte,T., van,O.J. and Myin-Germeys,I., 2008. Fluctuations in self-
esteem and paranoia in the context of daily life. J Abnorm Psychol. 117, 143-153. 
Trower,P., 2004. Cognitive therapy for command hallucinations: randomised controlled trial. 
Upthegrove,R., Birchwood,M., Ross,K., Brunett,K., McCollum,R. and Jones,L., 2010. The evolution of 
depression and suicidality in first episode psychosis. Acta Psychiatr Scand. 122, 211-218. 
Van Dongen,C.J., 1996. Quality of life and self-esteem in working and nonworking persons with 
mental illness. Community Ment Health J. 32, 535-548. 
van Os,J., Hanssen,M., Bijl,R.V. and Ravelli,A., 2000. Strauss (1969) revisited: a psychosis continuum 
in the general population? Schizophr Res. 45, 11-20. 
van Os,J. and Kapur,S., 2009. Schizophrenia. Lancet. 374, 635-645. 
van Os,J., Kenis,G. and Rutten,B.P., 2010. The environment and schizophrenia. Nature. 468, 203-212. 
van Os,J., Linscott,R.J., Myin-Germeys,I., Delespaul,P. and Krabbendam,L., 2009. A systematic review 
and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-
persistence-impairment model of psychotic disorder. Psychol Med. 39, 179-195. 
Van Os,J., Linscott,R.J., Myin-Germeys,I., Delespaul,P. and Krabbendam,L., 2009. A systematic review 
and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-
persistence-impairment model of psychotic disorder. Psychol Med. 39, 179-195. 
Ventura,J., Liberman,R.P., Green,M.F., Shaner,A. and Mintz,J., 1998. Training and quality assurance 
with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res. 79, 163-173. 
Verdoux,H., Liraud,F., Gonzales,B., Assens,F., Abalan,F. and van,O.J., 1999. Suicidality and substance 
misuse in first-admitted subjects with psychotic disorder. Acta Psychiatr Scand. 100, 389-395. 
81 
 
Voges,M. and Addington,J., 2005. The association between social anxiety and social functioning in 
first episode psychosis. Schizophrenia Research. 76, 287-292. 
Vracotas,N., Iyer,S.N., Joober,R. and Malla,A., 2010. The role of self-esteem for outcome in first-
episode psychosis. Int J Soc Psychiatry. 
Walinder,J. and Rutzt,W., 2001. Male depression and suicide. Int Clin Psychopharmacol. 16 Suppl 2, 
S21-S24. 
Watson,P.W., Garety,P.A., Weinman,J., Dunn,G., Bebbington,P.E., Fowler,D., Freeman,D. and 
Kuipers,E., 2006. Emotional dysfunction in schizophrenia spectrum psychosis: the role of 
illness perceptions. Psychol Med. 36, 761-770. 
Yanos,P.T., Roe,D., Markus,K. and Lysaker,P.H., 2008. Pathways between internalized stigma and 
outcomes related to recovery in schizophrenia spectrum disorders. Psychiatr Serv. 59, 1437-
1442. 
Yung,A.R. and McGorry,P.D., 1996. The prodromal phase of first-episode psychosis: past and current 
conceptualizations. Schizophr Bull. 22, 353-370. 
Zubin,J. and Spring,B., 1977. Vulnerability--a new view of schizophrenia. J Abnorm Psychol. 86, 103-
126. 
 
 
 
 
 
  
 
 
 
 
 
 
I

II

1 
 
Self-esteem is associated with premorbid adjustment and positive 
psychotic symptoms in first episode psychosis. 
 
Kristin Lie Romm,  MD1,  Jan Ivar Rossberg, MD, PhD1,2 , Charlotte Fredslund Hansen, MSc 
(Psy) 3, Elisabeth Haug, MD4,  Ole A. Andreassen, MD, PhD1,2, Ingrid Melle, MD, PhD1,2 
 
1Division of Mental Health and Addiction, Oslo University Hospital, 0407 Oslo, Norway 
2Department of psychiatry, University of Oslo, 0318 Oslo, Norway 
3Department of Psychology, University of Oslo, 0318 Oslo, Norway 
4Department of Psychosis and Rehabilitation, Sykehuset Innlandet HF, Norway 
Short title: Self-esteem among first episode psychosis patients 
 
 
Corresponding author: 
Kristin Lie Romm MD 
Research Fellow 
k.l.romm@medisin.uio.no 
Section for Psychosis Research, Department of Psychiatry 
Building 49, Oslo University Hospital 
0407 Oslo, Norway 
Tlf: 0047 97009863 
Fax: 0047 23027333 
 
 
2 
 
Abstract: 
Objective: Low levels of self esteem have been implicated as both a cause and consequence 
of severe mental disorders. The main aims of the study were to examine whether premorbid 
adjustment has an impact on the person’s self-esteem and whether lowered self-esteem 
contributes to the development and persistence of delusions and hallucinations.  
Method: A total of 113 patients from the Thematically Organized Psychosis research study 
(TOP) were included at first treatment. The Positive and Negative Syndrome Scale (PANSS) 
were used to assess present symptoms, premorbid adjustment was measured with the 
Premorbid Adjustment Scale (PAS) and self-esteem by the Rosenberg Self-Esteem Rating 
Scale (RSES).  
Results: Premorbid social adjustment was significantly related to lower self-esteem, and 
explained a significant proportion of the variance in self-esteem. Self-esteem was 
significantly associated with the level of persecutory delusions and hallucinations and 
explained a significant proportion of the variance regarding both symptoms, even after 
adjusting for depression in the final model.  
Conclusion: Premorbid functioning is an important aspect in development of self- esteem. 
Self esteem appears to play a significant role in the development of delusions and 
hallucinations.  
Keywords: Self-esteem, First episode psychosis, Schizophrenia, Premorbid adjustment, 
Delusions, Hallucinations 
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Introduction 
Self-esteem is a global and complex concept, comprising appraisal of self- worth 
based on personal achievements and anticipation of evaluation by others [1,2]. Even though 
not uniformly low,  self-esteem is  often found to be compromised among persons with 
mental illnesses [3]. Here, low self-esteem is of considerable interest because it is both a 
possible consequence and a cause of psychiatric symptoms [4-6].   Concerning the first, 
studies not surprisingly show that stigmatization and self-stigmatization may lower self-
esteem in persons with mental illness [7].  On the other hand, low self-esteem also appears 
to increase the risk of psychiatric disorders such as depression, eating disorders and 
substance abuse [8].  In psychotic disorders, low self-esteem has been implicated in both the 
development of delusions [9,10] and the maintenance of psychotic symptoms [11].  
Recent models of global self-esteem suggest that it is both a trait and a state  
measure [12]. People have a typical, average or trait level of self-esteem, while their 
momentary or state judgments of self-esteem can fluctuate around this level dependent on 
social feed-back and self-judgment. Furthermore, it is the person's interpretation of the 
event or circumstance, and its relevance to his or her contingencies of self-worth, that 
determines both if and how strongly an event will affect state self-esteem [12,13]. How 
treatment failures, functional loss, demoralization and stigmatization may lower self-esteem 
in patients with severe mental illnesses appears evident.  To what extent low levels of self-
esteem in severe mental disorders could be based on underlying or trait levels of self-
esteem, and how this in turn may increase vulnerability to more severe symptoms, is not 
thoroughly explored.   This is of importance both for understanding the mechanisms behind 
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the development of psychotic symptoms, and also for improving treatment as self-esteem 
can be influenced by therapeutic interventions [14,15]. 
One would assume that people’s trait levels of self-esteem would be affected by early 
childhood and adolescence experiences. In line with this, studies have suggested that 
difficult childhood experiences such as childhood loss and social marginalization contribute 
to a cognitive vulnerability accompanied by a negative view both towards the person himself 
and towards others [4,11,16]. Here one could hypothesize that individuals with a history of 
poor premorbid adjustment (both social and academic) could be more prone to negative 
self-evaluation and reduced global self-esteem. To our knowledge only one study has tried 
to examine the relationship between premorbid adjustment and self-esteem in patients with 
schizophrenia spectrum disorder [17].  They found no relationships between self-esteem and 
premorbid adjustment in recovered psychotic patients.  Premorbid adjustment was however 
not captured with a specific instrument which may account for the negative results. 
There is a relatively rich literature on the relationship between low self esteem and 
symptom formation in severe mental disorders. Bowins and Shugar found that the contents 
of patients’ delusions were consistent with patients’ global self esteem, and suggested that 
low self-esteem accounted for the persistence of delusions [18].  Barrowclough and 
colleagues found a  significant correlations between negative self-evaluation and a wider 
variety of positive symptoms (hallucinations and delusions) in schizophrenia [10], while 
Smith and coworkers found that patients with a low level of self-esteem and more 
depressive symptoms had more intense auditory hallucinations with a more negative 
content [19]. 
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 Other studies have on the other hand, found higher levels of self-esteem in patients 
with delusional disorder compared to depressed patients [20]. However, they found that the 
group without depressive symptoms had significantly higher levels of grandiose ideation 
than the other groups, which may account for the elevated levels of self-esteem. The 
authors concluded that persecutory delusions may reflect an attributional style protecting 
the individual from low self-esteem. Other studies have found equal levels of self-esteem in 
patients with delusions and matched healthy controls with  both groups demonstrating  
higher levels than depressed patients [21].  
Previous studies on the relationship between premorbid adjustment, low self esteem 
and positive symptoms have all been done in patients with chronic psychotic disorders, 
where the effects of a long-term severe illness may significantly confound relationships.   
To our knowledge, no previous studies have examined this in patients coming to their first 
treatment for a psychotic disorder with less prominent effects of treatment failures and 
subsequent disappointments. The aims of the current study are thus to investigate in a large 
and well characterized group of patients with first episode psychosis (FEP):   
1) To what extent is premorbid adjustment (measured by the Premorbid Adjustment Scale 
(PAS)) related to self-esteem (measured by the Rosenberg Self- Esteem Scale (RSES)) in this 
patient group?  
2) To what extent is self -esteem related to the level of hallucinations (measured by the 
Positive and Negative Syndrome Scale (PANSS))?  
3) To what extent is self-esteem related to the level of delusions in general and persecutory 
delusions in particular (measured by the Positive and Negative Syndrome Scale (PANSS))? 
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2.  Method 
2.1 Subjects 
From February 2007 through October 2009, 113 FEP patients from the main 
psychiatric treatment centres in Oslo and two neighbouring counties were consecutively 
included in the Thematically Organized Psychosis research study (TOP). The inclusion criteria 
were: 1) age 18 - 65 years and 2) coming to their first treatment for a non-affective psychosis 
according to DSM-IV. Exclusion criteria were a history of organic brain disorder, a significant 
co-morbid medical condition or an IQ of less than 70. The diagnostic distribution was as 
follows (N (%)): schizophrenia 68 (60.2%), schizophreniform disorder 7 (6.2%) schizoaffective 
disorder 11 (9.7%), brief psychosis 1 (0.9%) delusional disorder 7 (6.2%) and psychosis NOS 
19 (16.8%). 
Patients were eligible for inclusion up to 52 weeks after the start of first adequate 
treatment for their disorder and were not considered as FEP patients if they previously on 
any occasion had been treated with antipsychotic medication in adequate dosage for more 
than 12 weeks or until remission. Being psychotic was defined as having a rating of 4 or more 
on the PANSS items p1 (delusions), p2 (disorganisation), p3 (hallucinations), p5 (grandiosity), 
p6 (persecutory delusions) or g9 (unusual thought content) for more than one week. The 
mean age of the patients was 25.8 (SD 7.7), 37 (32.7%) were females, 82 (72.6%) were 
single, 24 (21.2%) were married/cohabiting, 7 (6.3%) were divorced/separated/widowed.  
Mean years of education were 12.4 (SD 2.72) and median duration of untreated psychosis 
(DUP) was 78 weeks (range 0-1040) (N=106). All patients gave written informed consent and 
the study was approved by the regional research ethics committee. 
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2.2 Assessments 
2.2.1 Measures 
Diagnosis was set according to the Structured Clinical Interview for Diagnostic and 
Structural Manual of Mental Disorders, fourth version (SCID I interview for the DSM -IV) [22]. 
Current severity of psychotic symptoms was measured with the Structural Clinical Interview 
of the Positive And Negative Syndrome Scale (SCI-PANSS) [23]. Self-esteem was measured 
using the Rosenberg Self-Esteem Scale (RSES)  [24]. This is a 10-item self-administered 
questionnaire with a 4-point likert-type response set, ranging from strongly disagree to 
strongly agree. Depression was diagnosed according the criteria for DSM-IV. We only 
measured Major depression to avoid overlap with negative symptoms. DUP was measured 
according to previously published criteria [25]. Premorbid adjustment was measured with 
the Premorbid Adjustment Scale (PAS) [26]. The premorbid phase is defined as the time from 
birth until 6 months before onset of psychosis. It measures both social and academic 
functioning during four age ranges. We only included the age range of childhood (-11 years) 
and early adolescence (12–15 years) as the usual onset of schizophrenia spectrum disorders 
is in early adulthood. We thus tried to avoid ‘contaminating’ the premorbid period as it can 
be difficult to point out the exact time point of conversion to psychosis, especially in 
individuals with insidious onset. Information was collected within each age range from the 
patient, medical journal and from significant family members when appropriate, to make 
ratings on items regarding sociability and withdrawal, peer relationships, academic 
performance and adaptation to school. 
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2.2.2. Procedures 
The patients were interviewed by trained psychologists and psychiatrists at the same 
time as the SCID-I was administered.  The investigators had all completed the general 
training- and reliability program in the TOP research study. For DSM-IV diagnostics, mean 
overall kappa with training videos was 0.77, and mean overall kappa for a randomly drawn 
subset of actual study patients was also 0.77 (95% CI 0.60-0.94). Inter-rater reliability, 
measured by the intra class correlation coefficient (ICC 1.1), was for the PANSS positive 
subscale 0.82 (95% CI 0.66–0.94), for the PANSS negative subscale 0.76 (95% CI 0.58–0.93) 
and the PANSS general subscale 0.73 (95% CI 0.54–0.90). 
3. Statistical analysis 
Correlations between demographic/clinical characteristics and self-esteem were calculated 
as Pearson’s product moment coefficients. To estimate how much of the variance in self-
esteem was explained independently by premorbid functioning, we performed a blockwise 
hierarchical multiple regression analysis with age and gender entered in the first block and 
premorbid adjustment in the second block. As academic adjustment in childhood versus 
academic adjustment in early adolescence, and social adjustment in childhood versus social 
adjustment in early adolescence were strongly inter correlated (with r=0.66 and 0.77; 
respectively), only results for early adolescence were entered to represent PAS and avoid co-
linearity problems. The associations between global self-esteem and hallucinations and 
delusions (general and persecutory) were analyzed similarly using Pearson’s correlations and 
followed up with three block-wise hierarchical multiple regression analysis with 
hallucinations, delusions and persecutory delusions as the dependent variables; 
demographic information in the first block (as this must be considered as the most basic 
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ones), depression (whether the patient was in a major depressive episode or not) in the 
second and self-esteem in the third. By entering self-esteem in the third, we controlled for 
the amount of variance explained by the variables in the two first blocks. 
4. Results 
Table 1 shows the patient characteristics of the 113 included patients.  
 
    Insert table 1 about here. 
 
As displayed in table 2, self-esteem was significantly correlated with several 
demographic and clinical characteristics, including the four subscale measures of premorbid 
adjustment and with the levels of symptoms (depression, persecutory delusions and 
hallucinations). Furthermore, females reported lower self-esteem. 
 
Insert table 2 about here. 
 
In the first hierarchical multiple regression analysis with self-esteem as the 
dependent variable the included variables explained 25 % of the variance in self-esteem 
(Table 3). Only gender and social adjustment in early adolescence contributed significantly to 
the explained level of global self-esteem.  Gender explained 16 % of the variance while 
premorbid social adjustment explained additionally 9 %.  
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Insert table 3 about here. 
 
In the second set of hierarchical multiple regression analyses with positive psychotic 
symptoms as dependent variables, self-esteem explained a significant amount of the 
variance; respectively 11 % in hallucinations (p3) and 7 % in persecutory delusions (p6). This 
was after adjusting for age, gender and depression, 
 
Insert table 4 about here. 
 
5. Discussion 
 
The main findings of this study are the demonstration of statistically significant 
relationships between poor premorbid social adjustment and low levels of global self-
esteem on the one hand, and between self-esteem and positive psychotic symptoms 
(hallucinations and persecutory delusions) on the other hand. The last finding remained 
significant even after adjusting for the presence of a major depressive episode indicating 
that this effect is not mediated by the presence of depressive symptoms.  
The current study is thus the first to show a relationship between poor premorbid 
social adjustment and level of global self-esteem in psychotic disorders. The only other study 
exploring this relationship [17] did not apply a specific validated measure of premorbid 
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adjustment (i.e. as the PAS), but did instead dichotomize collections of information based on 
the Diagnostic interview for Psychosis (DIP) as ‘yes’ versus ‘no’ poor premorbid adjustment, 
which implies both a less validated measure and a subsequent loss of variance in statistical 
analyses. In addition their sample consisted of older participants with a longer duration of 
illness, and thus a higher risk for recall bias. Premorbid social adjustment as a concept 
incorporates issues ranging from how you interact with your schoolmates, adjust to groups 
and friends and the presence of age-relevant sexual interest. Previous studies have shown 
that general cognitive abilities, exposure to bullying, social marginalization, abuse/neglect or 
the presence of neurodevelopmental factors are the strongest predictors of social 
adjustment [27-29]. Patients with psychotic disorder most probably have a premorbid 
vulnerability that might reduce their ability to achieve and maintain social competence and 
thus affects premorbid social adjustment [9,11,30]. This will in turn affect the individuals 
schematic beliefs about self and others that are dependent upon how we experience 
ourselves in relation to the world and thus lead to social adversity and a feeling of low self-
esteem [16]. This is not contradictory to Bentall et al.’s model as attributional style will be 
affected by these same factors, whether it is an expression of genetic vulnerability, 
neurodevelopmental factors or the result of environmental effects [9]. The present study 
gives empirical support to these considerations.  
The findings regarding premorbid adjustment are also of interest for social and 
cognitive models expressed by social ranking theory [31].  Studies of persons with auditory 
hallucinations have shown that voice hearers experiences  a subordinate relationship  to 
their voices mirroring other social relationships and suggesting the existence of maladaptive  
interpersonal schemata serving both [32]. These schemata are not necessarily a result of the 
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psychotic illness, but a result of premorbid poor social adjustment and might be seen in line 
with theories of how long term experience of social defeat, can be a risk factor for psychosis 
[27].    
Furthermore, we found self-esteem to be a predictor of both hallucinations and 
persecutory delusions in FEP. This is in line with previous studies [10,19,33,34]. Garety’s 
cognitive model of psychosis [11] suggests that the experience of social adversity and 
lowered self-esteem eventually can lead to the development of psychotic symptoms through 
an increased vulnerability for psychotic disorders. We would further argue that poor 
premorbid social adjustment with social withdrawal and subsequent marginalization will 
provide content to psychotic attribution by lack of correcting sources. This is supported by 
findings in studies of patients at high risk of developing psychosis [35]. In line with this, 
cognitive behavioral therapy aiming to improve self-esteem with focus on correcting 
misattributing tendencies has showed clinical benefits in terms of both increased self-
esteem, reduced positive symptoms and improved social functioning [14].  
This is also supported by findings in the general population. Negative ideas about 
oneself and others have been found  to predict paranoid thinking in the general population 
[36].  Furthermore, premorbid neuroticism and low self-esteem were associated with 
subsequent development of psychosis or psychosis like symptoms at 3-year follow-up in a  
Dutch population sample [37]. If we take the continuum hypothesis of psychosis into 
consideration [38], it is not surprising to find the same pattern in a FEP sample as the 
present. On the other hand, there are studies showing that patients self-stigma tends to be 
most affected during the early course of the disease, and that self-stigma and self-esteem 
are closely related [39]. It might be different subgroups within the psychosis spectrum that 
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differs with regard to both stability in self-esteem and which factors (long-term/short-term) 
that constitutes the most potent impact on the individuals’ self-esteem level. Further 
research into these complex mechanisms needs to be explored further in longitudinal 
studies.  
Gender turned out to be a significant predictor of self-esteem in this FEP sample, 
even after correction for differences in levels of depression, with women having significantly 
lower levels of self-esteem than men. A vast body of literature from the general population 
indicate a small but significant gender difference in the same direction [40]. There is 
surprisingly little research on gender-differences regarding self-esteem in psychosis, but the 
present study is supported by findings from the Danish Opus trial [41], and suggests that 
gender differences is a factor which warrants further investigation.  
The present study has some limitations. This is a cross-sectional study where 
conclusions about directions of relationships cannot be ascertained, and where data on 
premorbid adjustment necessarily are gathered retrospectively. There might be a recall bias 
regarding the scores for premorbid adjustment. To what degree self-esteem is affected 
before the development of psychosis is thus not possible to test directly using the current 
design.  
Conclusion: The current study revealed both a significant association between 
premorbid adjustment and self-esteem and between self-esteem and positive psychotic 
symptoms (persecutory delusions and hallucinations).  Future studies in self-esteem should 
consider looking into how self-esteem changes over time from the prodromal phase and 
over the course of illness. 
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Table 1. Demographics, n = 113. 
      
  
Mean 
 
±SD 
(%) 
Age 25.79 ±7.7 
Female (N/%) 37 (32.7) 
Years of education 12.4 ±2.72 
DUP (mean/median) (N=106) 78 (0-1040) 
PANSS: 
Positive score 17.4 ±4.21 
Negative score 16.28 ±6.03 
General score 36.74 ±8.03 
Total score 69.99 ±15.14 
RSES 22.81 ±6.16 
Depression MDE (N/%) 24 (21.24) 
Diagnosis (N/%) 
Schizophrenia 68 (60.18) 
Schizoaffective disorder 11 (9.73) 
Schizophreniform disorder 7 (6.19) 
Delusional disorder 7 (6.19) 
Psychosis NOS 19 (16.81) 
Brief psychosis 1 (0.88) 
Abbreviations: 
DUP; Duration of Untreated Psychosis  
PANSS; Positive and negative syndrome 
scale  
RSES; Rosenberg self-esteem scale  
MDE; Major Depressive Episode 
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Table 2. Clinical characteristics and their correlations with self esteem 
 Mean ±SD RSES ( r) 
RSES 22.81 ±6.14 1.00 
Age 25.79 ±7.70 0.08 
Gender (Female) (N/%) 37 32,7  - 0.41** 
PAS    
Childhood social 2.76 ±3.22 -0.27** 
Childhood academic 3.96 ±2.93 -0.19* 
Early adolescence social 3.56 ±3.30 -0.30** 
Early adolescence academic 4.93 ±2.90 -0.22* 
PANSS    
Hallucination 3.24 ±1.65 -0.29** 
Delusions 3.85 ±1.32    -0.17 
Persecutory delusions 3.33 ±1.50 -0.30** 
Depression MDE 1.79 ±0.41  0.28** 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
Abbreviations:  
RSES; Rosenberg self-esteem scale  
PAS; Premorbid adjustment scale 
PANSS; Positive and negative syndrome scale  
MDE; Major Depressive Episode 
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 Table 3. Multiple hierarchical regression analysis with self-esteem as the dependent variable. 
Model 
Unstand-
ardized 
Coef-
ficients 
Standard- 
ized 
Coefficients t Sig. 
95% Confidence 
Interval for B 
Adjusted R 
Square 
 B Std. 
Error 
Beta   Lower 
Bound 
Upper 
Bound 
 
Age 0.04 0.07 0.05 0.67 0.507 -0.09 0.17  
Gender -5.35 1.07 -0.41 -5.00 0.001 -7.47 -3.23 0.16 
Early adolescence social (PAS) -0.43 0.17 -0.23 -2.55 0.012 -0.77 -0.10  
Early adolescence academic (PAS) -0.29 0.19 -0.14 -1.51 0.133 -0.67 0.09 0.25 
Explained variance for  final model: R2=0.25, F=10.19, p<0.001 
Dependent Variable: Rosenberg self-esteem scale (RSES) 
 
Abbreviations:  
PAS; Premorbid adjustment scale 
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Table 4. Multiple hierarchical regression analysis with hallucinations and delusions and 
persecutory delusions as the dependent variables. 
  
Unstandardized 
Coefficients 
Standardized 
Coefficients t Sig. 
95% 
Confidence 
Interval for 
B 
Adjusted 
R Square 
  B Std. Error Beta   
Lower 
Bound 
Upper 
Bound  
Age -0.05 0.02 -0.21 -2.39 0.018 -0.08 -0.01  
Gender 0.31 0.34 0.09 0.91 0.364 -0.36 0.99 0.08 
Depression 
MDE 
-0.36 0.37 -0.09 -0.97 0.334 -1.10 0.38 0.09 
RSES -0.06 0.03 -0.21 -2.11 0.037 -0.11 0.00 0.12 
Explained variance for  final model: R2 =0.12, F=4.65, p=0.002 
a. Dependent Variable: Hallucinations (PANSS p3) 
    
          
Age 0.01 0.02 0.05 0.49 0.622 -0.02 0.04  
Gender -0.48 0.29 -0.17 -1.68 0.097 -1.05 0.09 -0.01 
Depression 
MDE 
0.16 0.31 0.05 0.51 0.613 -0.46 0.78 -0.02 
RSES -0.05 0.02 -0.25 -2.39 0.019 -0.10 -0.01 0.02 
Explained variance for  final model: R2=0.02, F=1.63, p= n.s. 
a. Dependent Variable: Delusions (PANSS p1) 
     
          
Age 0.03 0.02 0.14 1.54 0.127 -0.01 0.06  
Gender -0.08 0.32 -0.03 -0.25 0.802 -0.71 0.55 0.01 
Depression 
MDE 
0.25 0.34 0.07 0.71 0.477 -0.44 0.93 0.00 
RSES -0.08 0.03 -0.34 -3.30 0.001 -0.13 -0.03 0.08 
Explained variance for  final model: R2=0.08, F=3.46, p=0.01 
a. Dependent Variable: Persecutory delusions (PANSS p6)     
  
 
Abbreviations:  
MDE; Major Depressive Episode  
RSES; Rosenberg self-esteem scale,  
PANSS; Positive and negative syndrome scale  
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Abstract: 
Objective: Social anxiety is a frequent feature of psychotic disorders. The relationship 
between anxiety and other clinical characteristics and functioning is not yet fully understood. 
The main aims of the present study were to examine whether first episode psychosis patients 
with severe social anxiety shows poorer premorbid functioning, higher level of current 
clinical symptoms, better insight, lower current functioning and reduced quality of life.  
Method: A sample of 144 individuals with a first episode psychosis was divided into three 
groups dependent upon current level of social anxiety symptoms measured by the Liebowitz 
social anxiety scale, self-rated version; 1) no social anxiety (no-SaD), 2) clinically relevant 
symptoms of social anxiety (SaD) and 3)  generalized social anxiety symptoms (G- SaD). 
Analysis of variance was performed including measures of demographic and clinical 
characteristics. Furthermore, a hierarchical regression analysis was performed to explore 
possible predictors of quality of life.  
Results: Being in the G-SaD group was associated with poorer premorbid adjustment, lower 
social functioning and higher levels of depression, while there were no group differences in 
level of psychotic symptoms. Furthermore, the G-SaD group revealed a higher awareness of 
illness and experienced reduced quality of life. Social anxiety predicted quality of life even 
when adjusted for psychotic symptoms and depression. 
Conclusion: Severe social anxiety in first episode psychosis is to a larger extent associated 
with poor premorbid functioning and depression than to current level of psychotic symptoms, 
and is furthermore, an important predictor of quality of life.  
Keywords: First episode psychosis, Schizophrenia, Social phobia, Social anxiety, Premorbid 
adjustment, Quality of life 
3 
 
1. Introduction 
Social anxiety disorder has lately received increased interest, as it is the most prevalent form 
of anxiety disorder in schizophrenia. A meta-analysis (Achim et al., 2009) showed pooled 
overall prevalence rates for social anxiety disorder in schizophrenia to be approximately 15% 
with a variation from 14 % to 39 % between the different studies (Bermanzohn et al., 
2000;Cassano et al., 1999;Cosoff and Hafner, 1998;Pallanti et al., 2004).  
Three possible pathways are described to explain the association between social anxiety and 
psychosis (Birchwood et al., 2006;Voges and Addington, 2005); 1) Social anxiety disorder 
explained as a premorbid developmental disorder and perceived as a vulnerability marker for 
psychosis 2) Social anxiety disorder emerging concurrently with and constituting a core 
component of the psychotic syndrome, and 3) Social anxiety disorder emerging as a 
psychological reaction to the psychotic episode. 
Concerning the first possible pathway, that social anxiety disorder may evolve as part of  a 
premorbid developmental disorder, Birchwood and coworkers did not find any differences in 
premorbid peer-relations in a group of first episode patients with social anxiety disorder 
compared to first episode patients without social anxiety disorder (Birchwood et al., 2006). 
This is in contrast to the Edinburgh High-Risk Study that found early “situational anxiety” to 
be one of the best predictors of conversion to psychosis (Johnstone et al., 2005;Owens et al., 
2005). If social anxiety disorder in patients with psychosis represents a pre-morbid disorder 
with interpersonal difficulties we would expect that patients with severe social anxiety 
symptoms would show poorer premorbid functioning, specifically reduced social adjustment, 
when compared to patients without social anxiety disorder.  
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Concerning the second possible pathway, there are some support for the view that social 
anxiety is a core component of the psychotic syndrome, or at least a co-occurring process that 
might both initiate and exacerbate positive psychotic symptoms (Freeman et al., 2008). 
However, Michail and coworkers (Michail and Birchwood, 2009) did not find any 
relationship between positive symptoms and social anxiety. This is in line with a study by  
Pallanti and colleagues  (Pallanti et al., 2004) who found no relationship between neither 
positive nor negative symptoms and social anxiety. Others again have found social anxiety to 
be related to negative symptoms only, and not to positive symptoms (Voges and Addington, 
2005). If social anxiety disorder is a core component of the psychotic syndrome, we would 
expect a close relationship between social anxiety symptoms and current severity of psychotic 
symptoms.  
The third pathway perceives social anxiety as a result of the psychotic episode. Embedded in 
this theory lies the patients appraisals of psychosis involving perceived stigma, shame, loss of 
social role and enforced low status (Iqbal et al., 2000). This is followed by reduced self-
esteem and development of social anxiety (Gumley et al., 2004).  Implicit in this theory lies 
the assumption that insight into illness to some extent has an impact on self-esteem. Self-
esteem is after all dependent upon how we view ourselves in relation to others.  
Quality of life (QoL) measures are considered as an important part of outcome assessment in 
psychosis (Melle et al., 2005). Only few studies have focused on the relationship between 
social anxiety and QoL in patients with psychosis and more studies have been asked for 
(Huppert et al., 2001). Two studies, including patients with chronic psychosis, have revealed a 
close relationship between social anxiety and reduced QoL (Pallanti et al., 2004;Halperin et 
al., 2000). Furthermore, one study found that QoL to a larger extent were related to depression 
than to current psychotic symptoms (Fitzgerald et al., 2001;Kusel et al., 2007)  while another 
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study revealed that QoL was strongly related to negative symptoms only (Kusel, 2007). Few 
studies have investigated social anxiety in patients with first episode psychosis (Birchwood et 
al., 2006;Voges and Addington, 2005;Michail and Birchwood, 2009). Studying patients in 
early phases is associated with a reduced recall bias with regard to premorbid functioning and 
less risk of blending of psychotic symptoms such as persecutory delusions and social anxiety 
(Michail and Birchwood, 2009). Overall, to study phenomena proximal to early development 
of psychosis is important as this period has shown to be very important for later course and 
important outcome measures (Fenton, 2000;Birchwood et al., 1998).  No previous study have 
examined to what extent social anxiety predict subjective QoL in first episode psychosis 
patients, controlling for important clinical variables such as depression, positive and negative 
symptoms. 
To sum up, there might exist several and possibly overlapping pathways to social anxiety in 
psychosis. These are not yet fully understood, and only few studies are performed in samples 
of patients with a first episode psychosis. The purpose of the current study was to investigate 
further the different pathways of social anxiety in first episode psychosis and the impact of 
social anxiety on QoL. As we assumed that most of the patients would display some degree of 
social anxiety, we decided to look specifically into the group most affected. More specifically 
we aimed to answer the following research questions: Do patients with high levels of current 
social anxiety symptoms reveal 1) poorer premorbid functioning, 2) stronger associations to 
clinical correlates such as current psychotic symptoms, depression and functioning and 3) 
better insight and lower self-esteem. Finally, we wanted to explore if social anxiety per se acts 
as an independent predictor of QoL. 
 
 
6 
 
Methods 
2.1 Subjects 
From February 2007 through October 2009, 144 FEP patients from the main psychiatric 
treatment centres in Oslo and two neighbouring counties were consecutively included in the 
ongoing Thematically Organized Psychosis (TOP) research study. The inclusion criteria were: 
1) age 18 - 65 years and 2) coming to their first treatment for a non-affective psychosis 
according to DSM-IV. Exclusion criteria were a history of organic brain disorder, a 
significant co-morbid medical condition or an IQ of less than 70. The diagnostic distribution 
was as follows: Schizophrenia 74 (51%), schizophreniform disorder 11 (8 %) schizoaffective 
disorder 13 (9 %), major depression with mood incongruent psychotic symptoms 8 (6%), 
psychosis NOS 38 (26%). 
Patients were eligible for inclusion up to 52 weeks after the start of first adequate treatment 
for their psychotic disorder, but were not considered as FEP patients if they previously on any 
occasion had been treated with antipsychotic medication in adequate dosage for more than 12 
weeks or until remission. The mean age of the patients were 26.3 (SD 8.4), 92 (64 %) were 
males and 112 (78%) were single.  Mean years of education were 12.4 (SD 2.6) and median 
duration of untreated psychosis (DUP) was 77 weeks (range 0-1040) (N=143). The study was 
approved by the regional research ethics committee. All patients gave written informed 
consent upon entry to the study. 
2.2 Assessments 
2.2.1 Measures 
Diagnosis was set according to the Structured Clinical Interview for Diagnostic and Structural 
Manual of Mental Disorders, fourth version (SCID I interview for the DSM -IV)(American 
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Psychiatric Association, 1994). Positive symptoms, negative symptoms and general 
psychopathology were assessed by the Structural Clinical Interview of the Positive and 
Negative Syndrome Scale (SCI-PANSS)(Kay et al., 1987) and divided into a five-factor 
model  reflecting Positive, Negative, Excitative, Depressive and Cognitive Components 
(Bentsen et al., 1996) .  
Social anxiety was measured by the self-rating version of the Liebowitz Social Anxiety Scale 
(LSAS-SR). The Liebowitz Social anxiety scale  (LSAS) (Liebowitz, 1987) is a widely used 
instrument, and comprises 24 items measuring fear and avoidance separately for 24 social 
situations over the past week. The self-report version has recently been satisfactorily validated 
in a first episode psychosis sample (Romm et al., 2010b). The scale was administered in 
connection with an interview session, and the patients had ample opportunity to ask questions. 
We chose the same way to instruct the patients about how to complete the questionnaire as 
described by Fresco et al. (Fresco et al., 2001).  
Insight was measured by the Insight Scale (IS) (Birchwood et al., 1994) and includes three 
dimensions of insight; ‘insight into illness’,’ insight into (psychotic) symptoms’ and ‘insight 
into need for treatment’.  
Self-esteem was measured using the Rosenberg self-esteem scale (RSES)  (Rosenberg, 1965). 
This is a 10-item self-administered questionnaire with a 4-point likert-type response set, 
ranging from strongly disagree to strongly agree, with low total score pointing towards low 
self-esteem. Premorbid adjustment was measured with the Premorbid Adjustment Scale 
(PAS) (Cannon-Spoor et al., 1982). The premorbid phase is defined as the time from birth 
until 6 months before onset of psychosis. It measures both social and academic functioning 
during four age ranges. We only included the age ranges of childhood (-11 years) and early 
adolescence (12–15 years) as the usual onset of schizophrenia spectrum disorders is in early 
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adulthood. In this manner we tried to avoid ‘contaminating’ the premorbid period as it can be 
difficult to point out the exact time point of conversion to psychosis, especially in individuals 
with insidious onset. Information was collected within each age range from the patient, 
medical journal and from significant family members when appropriate, to make ratings on 
items regarding sociability and withdrawal, peer relationships, academic performance and 
adaptation to school. Global functioning was measured by the split version of the Global 
assessment of functioning scale (GAF)(Endicott et al., 1976), which measures both symptoms 
and functioning per se (Pedersen et al., 2007). QoL was measured by one of the items, 
‘Satisfaction with life in general’, in the Lehman Quality of Life Interview (Lehman, 1988). 
This has a 7-point likert-type response set, ranging from “Terrible” to “Delighted”. A 
previous psychometric study has found statistically significant association between the 
“satisfaction with life in general” scale and all nine indices constituting the full-length version  
of the interview (Melle et al., 2005).  
 
2.2.2. Procedures 
The patients were interviewed by trained psychologists and psychiatrists at the same time as 
the SCID-I was administered.  The investigators had all completed the general training- and 
reliability program in the TOP research study. For DSM-IV diagnostics, mean overall kappa 
with training videos was 0.77, and mean overall kappa for a randomly drawn subset of actual 
study patients was also 0.77 (95% CI 0.60-0.94). Inter-rater reliability, measured by the intra 
class correlation coefficient (ICC 1.1), was for the PANSS positive subscale 0.82 (95% CI 
0.66–0.94), for the PANSS negative subscale 0.76 (95% CI 0.58–0.93) and the PANSS 
general subscale 0.73 (95% CI 0.54–0.90). 
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3. Statistics 
All analysis was carried out using SPSS Version 16.0. All hypothesis testing were two-tailed. 
Duration of untreated psychosis (DUP) was substituted in the multivariate analysis with 
ln(DUP+1) due to skewed data. Twenty-one of the 144 patients did not complete the 
Rosenberg self-esteem questionnaire as this was added to the study protocol at a later stage. 
Thus, the analysis concerning self-esteem is performed with fewer participants, but this sub-
group was not different from the whole group.  
We divided the sample according to Mennin et al. (Mennin et al., 2002) into three groups 
depending upon the LSAS-SR total score as we assumed there would be group differences 
according to severity of social anxiety symptoms; Total score < 30: no social anxiety (No-
SaD), 31-60: clinically relevant  social anxiety symptoms (SaD), >60: Generalized social 
anxiety (G-SaD). Analysis of variance (ANOVA) was carried out to compare group 
differences on demographic and clinical characteristics. Post-Hoc Tukey Honestly significant 
test was used to adjust for multiple comparisons. Effect sizes were calculated according to 
Cohen’s classification; 0.01 = small effect size, 0.06= medium effect and 0.14 = large effect 
(Cohen, 1988).   
A subanalysis was carried out using Pearson’s correlation to test whether ‘insight into illness’ 
was associated to psychotic symptoms in particular or other clinical symptoms such as 
depression and social anxiety.  
Finally, a hierarchical multiple regression analysis was carried out to assess the independent 
contribution of social anxiety on quality of life when adjusting for variables presumed to have 
an impact on quality of life, i.e. a theoretically driven regression analysis. Self-esteem was not 
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included in the analysis as it was intra correlated with both depression (r=-0.55) and social 
anxiety (r=-0.64).  
 
4. Results 
Demographic characteristics are shown in Table 1.  
  
     Insert Table 1 about here. 
 
According to the criteria of Mennin and colleagues (Mennin et al., 2002), 79% of the patients 
had some clinical symptoms that were associated with social anxiety disorder. A total of 68 
patients (47%) met the criteria for G-SaD.  No significant differences were detected for age, 
gender, education or primary diagnosis between Non-SaD, SaD and the G-SaD group. 
The ANOVA revealed that the most pronounced group differences were found between the 
G-SaD group and the other two, the SaD and Non-SaD group.  
 
     Insert table 2 about here. 
 
The G-SaD group performed poorer in both academic and social premorbid functioning. The 
partial Eta square confirmed moderate to large effect sizes in differences in social functioning 
both in childhood and early adolescence. Furthermore, a difference in DUP was revealed 
primarily between the G-SaD/SaD groups and the Non-SaD group. The trend was though that 
heightened level of SaD was running along with an increase in DUP.  
We did not find any differences between the groups with regard to neither positive- nor 
negative symptoms. The only significant findings concerning the different PANSS 
components were, as expected, for the depressive component. The G-SaD group differed 
11 
 
significantly from the two other groups with regard to GAF-symptoms, while GAF-
functioning revealed only a significant difference between the G-SaD and the Non-SaD 
group.   
The G-SaD group showed a significant lower level of self-esteem with a large effect size. The 
same pattern was obtained concerning the item ‘insight into illness’ where the effect size was 
likewise large. Neither ‘insight into symptoms’ nor ‘insight into need for treatment’ revealed 
any significant differences between the three groups.  
The subanalysis, to explore the associations between ‘insight into illness’ and clinical 
symptoms, revealed that ‘insight into illness’ was related to the depressive component of the 
PANSS (r=0.37, p<0.05) and self-esteem (r=-0.37, p<0.05) while no significant associations 
were found between ‘insight into illness’ and psychotic symptoms. 
To explore whether social anxiety symptoms predicted subjective quality of life adjusting for 
other important clinical variables, we performed a blockwise multiple hierarchical regression 
analysis. 
 
     Insert table 3 about here. 
 
Table 3 shows that in the final model, only depression and social anxiety had a statistically 
significantly contribution, with depression having a higher beta value (beta = 0.35, p<0.001) 
than social anxiety (beta = 0.23, p<0.05). Neither positive psychotic symptoms nor negative 
symptoms contributed significantly. 
 
 
 
5. Discussion 
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The main finding of the current study was that nearly half of the patients with a first episode 
psychosis experienced severe social anxiety problems when engaging in social interaction and 
performance. Patients with severe symptoms of social anxiety disorder revealed poorer 
premorbid and current functioning, more insight and lower self-esteem compared to patients 
with less- or no social anxiety symptoms. Furthermore social anxiety was a significant 
predictor of subjective quality of life. The study revealed no significant relationship between 
psychotic symptoms and social anxiety.  
We did not explore whether patients with severe social anxiety disorder met the DSM-IV 
criteria, but our findings are comparable to other studies. Voges and Addington (Voges and 
Addington, 2005) found 50-60 % of their sample of first episode patients to fall in the range 
of ‘a probable diagnosis of social phobia’, while 31 % actually met the criteria. Mazeh and 
coworkers (Mazeh et al., 2009) reported LSAS subscale mean scores (fear; 38.5, and 
avoidance; 37.7) in a sample of long term ill schizophrenia patients to be somewhat higher 
than in the current study (fear; 30 and avoidance; 29), but still comparable.  
The G-SaD group differed significantly on measures of premorbid functioning, specifically 
with regard to social adjustment. This is in line with previous findings (Johnstone et al., 
2005;Owens et al., 2005), but contrary to Birchwood and colleagues (Birchwood et al., 2006).  
We find it plausible to conclude that this might be a reflection of a possible neuro-
developmental pathway even though we have to underline that this is a cross-sectional study 
and as such do not allow us to draw any firm conclusion other than causative assumptions. 
However, there are other studies suggesting a link among shyness, schizophrenia and social 
dysfunction from early childhood (Goldberg and Schmidt, 2001). Others have found a link 
between reduced flexibility in abstract thought, flexibly shifting mind set and social anxiety 
(Lysaker and Hammersley, 2006;Lysaker et al., 2004) both in people with and without a 
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severe mental disorder(Easter et al., 2005;Hariri et al., 2003). Thus, a confluence of organic 
and psychological precipitating factors might be involved. This finding is also supported by 
the fact that the group with G-SaD had a significantly longer DUP than those with only minor 
or no problems with social anxiety. Overall, there was a trend towards longer DUP with rising 
level of anxiety. One possible explanation consistent with the findings in the Edinburgh high-
risk study as well, would be that some of these children have been actively withdrawn and to 
some degree deviant from an early age. The transition into psychosis might have been less 
pronounced and therefore not detected and treated properly at an earlier time point. Another 
option is that social anxiety inhibits the seeking of psychiatric care in general which would be 
in line with previous findings concluding that social anxiety disorder inhibits the seeking of 
psychiatric care for depressed patients (Pilkonis et al., 1980). This would inevitably prolong 
the DUP.  
The present study revealed no difference between the groups on current level of positive and 
negative symptoms. Symptoms of social anxiety and level of psychosis seems to be present 
together, but as more independent pathological entities. However, despite the lack of group 
differences concerning psychotic symptoms, we found that the G-SaD group revealed 
significant more depressive symptoms than the other two groups. This is in line with previous 
studies supporting a clear link between social anxiety and mood-symptoms (Kessler et al., 
1999) in the general population, and the conceptualisation of social anxiety as part of an 
emotional dysfunction complex in psychotic disorders (Birchwood, 2003). 
 
As expected the G-SaD group exhibited significantly lower levels of self-esteem than the 
other two groups. This could be part of a psychological reaction to psychosis as described in 
the ‘social rank’ or ‘perceived stigma’ theory (Iqbal et al., 2000;Gilbert, 2001), and should 
then be mirrored in the insight scores.  Patients with G-SaD did report a significant higher 
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level of ‘insight into illness’ compared to the other two groups, but there were no significant 
differences between the groups concerning ‘insight into (psychotic) symptoms’ or ‘need for 
treatment’. A previous study of social anxiety with similar findings (positive association 
between social anxiety and insight into illness only) has interpreted this as the patients 
awareness of their psychotic illness (Birchwood et al., 2006). However, the underlying items 
making up this factor consist of the following statements: 1) I am mentally well, 2) If 
someone said I have a nervous or mental illness they would be right. Another option could be 
that patients with severe concurrent disorders as G-SaD or depression are misinterpreting the 
questions and are reporting level of social discomfort and/or depression rather than insight 
into having a psychotic illness. This was supported by the sub analysis that failed to find any 
associations between psychotic symptoms and ‘insight into illness’, but found significant 
associations to depression and social anxiety. Furthermore, despite the fact that the three 
groups are almost identical regarding positive and negative symptoms, the G-SaD group differ 
both in GAF-s and GAF-f. This might reflect higher depression/social anxiety scores and/or 
reduced functioning due to depression and/or social anxiety with active withdrawal.  
To our knowledge, this is the first study to examine whether social anxiety is an important 
predictor of QoL even after adjusting for depression and psychotic symptoms. Both 
depression and social anxiety were significant predictors of subjective QoL. The present study 
support previous research that has pointed to the importance of incorporating targeted 
monitoring and treatment of affective and anxiety symptomatology in severe mental illness 
(Hansson, 2006).  The importance of being aware of depression is obvious as it is prevalent in 
psychosis (Romm et al., 2010a) and acts as an important contributor to the increased risk of 
suicide (Melle et al., 2006;Barrett et al., 2010).  Furthermore, this is of especially importance, 
since both social anxiety and depression rarely are the target of treatment and are often not 
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recognized in the clinic due to focus on the traditional positive and negative symptoms 
(Cosoff and Hafner, 1998;Schneier et al., 1992). Considering evidence for new therapeutic 
gains as CBT has been proven effective as adjunctive treatment for social anxiety  and 
depression in psychosis (Kingsep et al., 2003;Halperin et al., 2000), a more active approach 
towards recognition and treatment of social anxiety should be applied. Furthermore, a more 
focused living skills training to enhance social functioning targeted towards self-care, 
occupational, leisure and recreation, friendship and intimacy skills would be particularly 
relevant (Falloon et al., 1998).   
 
Limitations: 
Besides the cross sectional design, the skewed group sizes is a limitation. There are twice as 
many men as women; this is though comparable with other first episode studies. Furthermore, 
assessment and description of the diagnostic distribution with regard to a DSM-IV diagnosis 
of social anxiety disorder would be preferable, but not possible within the limits of this study. 
Future research would profit from exploring whether there exist an association between social 
anxiety disorders and reduced cognitive functioning in psychosis, as this may be a sign of a 
more developmental disorder, and would help explain why the most severly impaired group 
seem to differ on several clinical aspect compared to those with no or minor social anxiety 
symptoms.  
Conclusions:   
While symptoms of social anxiety are prevalent in first episode psychosis, those mostly 
impaired by social anxiety, exhibit distinct clinical characteristics and are more impaired on 
several measures.  Furthermore, social anxiety is a significant predictor of subjective quality 
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of life. Hence, a more active approach towards treatment of social anxiety during early phases 
of psychotic illness should be applied.  
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Table 1. 
Demographic and clinical characteristics (N=144) 
All patients Non-SaD N=30 SaD N=46 G-SaD N=68 
Age (years)(mean/SD) 26.27 8.45   25.47 8.91 28.67 10.78 25.00 5.83 
Male gender 92.00 63.90 21.00 70.00 31.00 67.39 40.00 58.82 
Education (years)(mean/SD) 12.38 2.63 12.30 2.88 13.03 2.86 11.99 2.29 
DIAGNOSIS: 
Schizophrenia  74.00 51.40 14.00 46.67 20.00 43.48 40.00 58.82 
Schizophreniform 11.00 7.60 5.00 16.67 5.00 10.87 1.00 1.47 
Schizoaffective 13.00 9.00 2.00 6.67 4.00 8.70 7.00 10.29 
Affective psychosis* 8.00 5.60 3.00 10.00 2.00 4.35 3.00 4.41 
Psychosis NOS 38.00 26.40   6.00 20.00 15.00 32.61 17.00 25.00 
N and % are given except when noted. 
*Major depression with mood incongruent psychotic symptoms 
NOS: Not Otherwise Spesified 
SaD: Social anxiety Disorder 
G-SaD: Generalized Social anxiety Disorder 
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